##analysisDate=2017-05-10-13-54-12000
##analyzedBy=RingStudy Site F
##exportDate=2017-11-08-10-46-37000
##analysisName=Site F-081-Sample 4_F
##workflowName=Oncomine Comprehensive v3 - w2.1 - DNA and Fusions - Single Sample
##sampleNames=Site F-081-Sample 4-F_v1:Site F-081-Sample 4-F_RNA_v1
##reference=hg19
##variantGroup=DEFAULT
##filterChain=Site D_NoRef
##searchText=
##chromosome=All
##totalVariantCount=2474
##filterInCount=124
##filteredOutCount=2350
##hiddenVariantCount=0
Locus	Genotype	Ref	Type	No Call Reason	Genes	Location	Length	Oncomine Variant Class	Oncomine Gene Class	Copy Number	CytoBand	Info	Variant ID	Variant Name	% Frequency	Amino Acid Change	Read Counts	Coverage	Allele Ratio	CNV Confidence	Detection	3'/5' Imbalance	COSMIC/NCBI	Read Counts Per Million	Strand	Exon	Transcript	Coding	Variant Effect	PhyloP	SIFT	Grantham	PolyPhen	PFAM	dbSNP	DGV	MAF	EMAF	AMAF	GMAF	UCSC Common SNPs	Gene Ontology	DrugBank	ClinVar	p-value	Phred QUAL Score	Allele Coverage	CNV Precision	Ref+/Ref-/Var+/Var-	Homopolymer Length	Tiles
chr1:40363054	C/C	G	SNV		MYCL	exonic	1								100.00	p.Thr392Ser		659	G=0.0, C=1.0		Present				-	3	NM_001033082.2	c.1175C>G	missense	1.32	1.0	58.0	0.0	Helix-loop-helix DNA-binding domain,Myc amino-terminal region	rs3134614		0.055 (ref)	0.1328	0.0252	0.0963	YES	DNA binding,nucleus,regulation of transcription, DNA-dependent,sequence-specific DNA binding transcription factor activity			0.00001	9963.08	G=0, C=659		G=0/0, C=328/331	1	
chr1:156811985		G	GENE_EXPRESSION		NTRK1								NTRK1.E3E4				59				Present			2.5956e-11																						0.0					
chr1:156838041		G	GENE_EXPRESSION		NTRK1								NTRK1-NTRK1.N6N8				191				Present			8.4028e-11																						0.0					
chr1:156849949		G	GENE_EXPRESSION		NTRK1								NTRK1.E16E17				1934				Present			8.5083e-10																						0.0					
chr1:204485637		G	GENE_EXPRESSION		MDM4								MDM4.E1E2				3804				Present			1.6735e-09																						0.0					
chr1:204494724		G	GENE_EXPRESSION		MDM4								MDM4-MDM4.M2M11				12089				Present			5.3184e-09																						0.0					
chr1:204494724		G	GENE_EXPRESSION		MDM4								MDM4-MDM4.M3M10				625				Present			2.7496e-10																						0.0					
chr1:204494724		G	GENE_EXPRESSION		MDM4								MDM4.E3E4				11586				Present			5.0971e-09																						0.0					
chr1:204499945		G	GENE_EXPRESSION		MDM4								MDM4-MDM4.M5M10				612				Present			2.6924e-10																						0.0					
chr1:204499945		G	GENE_EXPRESSION		MDM4								MDM4-MDM4.M5M7.S				986				Present			4.3378e-10																						0.0					
chr1:204507436		G	GENE_EXPRESSION		MDM4								MDM4-MDM4.M7M10				1853				Present			8.1520e-10																						0.0					
chr1:204512072		G	GENE_EXPRESSION		MDM4								MDM4-MDM4.M8M10				600				Present			2.6396e-10																						0.0					
chr2:48010488	G/A	G	SNV		MSH6	exonic	1								96.46	p.Gly39Glu		311	G=0.0354, A=0.9646		Present				+	1	NM_000179.2	c.116G>A	missense	0.84	0.06	98.0	0.0	MutS domain I,MutS domain II,MutS domain III,MutS domain V,MutS family domain IV,PWWP domain	rs1042821		0.193 (ref)	0.1724	0.194	0.1797	YES	ADP binding,ATP binding,ATP catabolic process,ATPase activity,DNA damage response, signal transduction resulting in induction of apoptosis,DNA repair,DNA-dependent ATPase activity,MutLalpha complex binding,MutSalpha complex,chromatin binding,damaged DNA binding,determination of adult lifespan,double-stranded DNA binding,four-way junction DNA binding,guanine/thymine mispair binding,induction of apoptosis by intracellular signals,isotype switching,magnesium ion binding,maintenance of DNA repeat elements,meiotic mismatch repair,mismatch repair,mismatched DNA binding,negative regulation of DNA recombination,nuclear chromatin,nuclear chromosome,nucleotide binding,nucleus,oxidized purine DNA binding,positive regulation of helicase activity,protein binding,protein homodimerization activity,reciprocal meiotic recombination,response to UV,single guanine insertion binding,single thymine insertion binding,somatic hypermutation of immunoglobulin genes,somatic recombination of immunoglobulin gene segments		non-pathogenic,probable-non-pathogenic	0.00001	4340.45	G=11, A=300		G=9/2, A=160/140	4	
chr3:37053568	A/G	A	SNV		MLH1	exonic	1								69.90	p.Ile219Val		2000	A=0.301, G=0.699		Present				+	8	NM_000249.3	c.655A>G	missense	2.21	0.17	29.0	0.018	DNA mismatch repair protein,Histidine kinase-	rs1799977		0.172	0.3202	0.0921	0.243	YES	ATP binding,ATP catabolic process,ATPase activity,DNA damage response, signal transduction resulting in induction of apoptosis,MutLalpha complex,MutLbeta complex,MutSalpha complex binding,cell cycle,cellular response to organic cyclic compound,chiasma,double-strand break repair via nonhomologous end joining,guanine/thymine mispair binding,isotype switching,male germ cell nucleus,male meiosis chromosome segregation,meiotic metaphase I plate congression,mismatch repair,mismatched DNA binding,negative regulation of mitotic recombination,nuclear-transcribed mRNA poly(A) tail shortening,nucleus,oogenesis,pachytene,protein binding,reciprocal meiotic recombination,resolution of meiotic recombination intermediates,response to drug,response to hypoxia,response to toxin,single-stranded DNA binding,somatic hypermutation of immunoglobulin genes,spermatogenesis,spindle midzone assembly involved in meiosis,synaptonemal complex		non-pathogenic,probable-non-pathogenic	0.00001	16131.3	A=602, G=1398		A=319/283, G=666/732	1	
chr3:142222284	A/G	A	SNV		ATR	exonic	1								71.83	p.(=)		1161	A=0.2817, G=0.7183		Present				-	30	NM_001184.3	c.5208T>C	synonymous	0.03				FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase,UME (NUC010) domain	rs2227931		0.352 (ref)	0.4189	0.2145	0.3496	YES	ATP binding,DNA binding,DNA damage checkpoint,DNA repair,DNA replication,MutLalpha complex binding,MutSalpha complex binding,PML body,XY body,cell cycle,cell cycle checkpoint,cellular response to UV,cellular response to gamma radiation,multicellular organismal development,negative regulation of DNA replication,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,positive regulation of DNA damage response, signal transduction by p53 class mediator,protein autophosphorylation,protein binding,protein kinase activity,protein phosphorylation,protein serine/threonine kinase activity,regulation of protein binding,replicative senescence,response to DNA damage stimulus			0.00001	9728.1	A=327, G=834		A=193/134, G=400/434	1	
chr3:142277536	A/G	A	SNV		ATR	exonic	1								71.80	p.(=)		2000	A=0.282, G=0.718		Present				-	8	NM_001184.3	c.1815T>C	synonymous	0.12				FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase,UME (NUC010) domain	rs2227929		0.349 (ref)	0.414	0.2127	0.3458	YES	ATP binding,DNA binding,DNA damage checkpoint,DNA repair,DNA replication,MutLalpha complex binding,MutSalpha complex binding,PML body,XY body,cell cycle,cell cycle checkpoint,cellular response to UV,cellular response to gamma radiation,multicellular organismal development,negative regulation of DNA replication,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,positive regulation of DNA damage response, signal transduction by p53 class mediator,protein autophosphorylation,protein binding,protein kinase activity,protein phosphorylation,protein serine/threonine kinase activity,regulation of protein binding,replicative senescence,response to DNA damage stimulus			0.00001	16847.2	A=564, G=1436		A=284/280, G=769/667	1	
chr3:142277575	A/T	A	SNV		ATR	exonic	1								70.22	p.(=)		1246	A=0.2978, T=0.7022		Present				-	8	NM_001184.3	c.1776T>A	synonymous	-0.09				FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase,UME (NUC010) domain	rs2227930		0.382 (ref)	0.405	0.2043	0.337	YES	ATP binding,DNA binding,DNA damage checkpoint,DNA repair,DNA replication,MutLalpha complex binding,MutSalpha complex binding,PML body,XY body,cell cycle,cell cycle checkpoint,cellular response to UV,cellular response to gamma radiation,multicellular organismal development,negative regulation of DNA replication,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,positive regulation of DNA damage response, signal transduction by p53 class mediator,protein autophosphorylation,protein binding,protein kinase activity,protein phosphorylation,protein serine/threonine kinase activity,regulation of protein binding,replicative senescence,response to DNA damage stimulus			0.00001	10069.2	A=371, T=875		A=200/171, T=486/389	1	
chr3:142281612	A/G	A	SNV		ATR	exonic	1								70.16	p.Met211Thr		1689	A=0.2984, G=0.7016		Present				-	4	NM_001184.3	c.632T>C	missense	0.55	1.0	81.0	0.0	FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase,UME (NUC010) domain	rs2227928		0.383 (ref)	0.4045	0.2072	0.3377	YES	ATP binding,DNA binding,DNA damage checkpoint,DNA repair,DNA replication,MutLalpha complex binding,MutSalpha complex binding,PML body,XY body,cell cycle,cell cycle checkpoint,cellular response to UV,cellular response to gamma radiation,multicellular organismal development,negative regulation of DNA replication,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,positive regulation of DNA damage response, signal transduction by p53 class mediator,protein autophosphorylation,protein binding,protein kinase activity,protein phosphorylation,protein serine/threonine kinase activity,regulation of protein binding,replicative senescence,response to DNA damage stimulus			0.00001	13636.5	A=504, G=1185		A=247/257, G=585/600	1	
chr4:1807894	A/A	G	SNV		FGFR3	exonic	1								100.00	p.(=)		1152	G=0.0, A=1.0		Present				+	14	NM_000142.4	c.1953G>A	synonymous	0.05				Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs7688609		0.042 (ref)	8.0E-4	0.131	0.0449	YES	ATP binding,JAK-STAT cascade,MAPKKK cascade,bone maturation,bone morphogenesis,chondrocyte differentiation,chondrocyte proliferation,cytoplasmic membrane-bounded vesicle,endochondral bone growth,endochondral ossification,endoplasmic reticulum,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,focal adhesion,insulin receptor signaling pathway,integral to plasma membrane,negative regulation of developmental growth,nucleotide binding,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of MAPKKK cascade,positive regulation of cell proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phospholipase activity,positive regulation of tyrosine phosphorylation of Stat1 protein,positive regulation of tyrosine phosphorylation of Stat3 protein,protein autophosphorylation,protein binding,protein tyrosine kinase activity,receptor activity,regulation of apoptotic process,skeletal system development	Palifermin,Pazopanib		0.00001	17489.8	G=0, A=1152		G=0/0, A=536/616	1	
chr4:55141051	GCCCGGATGGACATGA/GCCCGGATGGACATGA	GCCCAGATGGACATGA	SNV		PDGFRA	exonic	1					HS	COSM12418		G=0.00, GCCCGGATGGACATGA=100.00	p.(=)		1957	GCCCAGATGGACATGA=0.0, G=0.0, GCCCGGATGGACATGA=1.0		Present				+	12	NM_006206.4	c.1701A>G	synonymous	2.79,2.74,2.74,2.74,-5.31,2.74,2.21,0.99,2.74,2.74,0.41,2.64,2.31,-0.28,1.57,2.31				Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs121913270,rs121913271,rs1873778,rs201503614		0.037				YES	ATP binding,Leydig cell differentiation,adrenal gland development,cardiac myofibril assembly,cell activation,cell chemotaxis,cellular response to amino acid stimulus,cytoplasm,elevation of cytosolic calcium ion concentration,embryonic cranial skeleton morphogenesis,embryonic digestive tract morphogenesis,embryonic skeletal system morphogenesis,estrogen metabolic process,extracellular matrix organization,face morphogenesis,female gonad development,gliogenesis,growth factor binding,in utero embryonic development,inner ear development,integral to plasma membrane,intrinsic to plasma membrane,lung development,luteinization,male genitalia development,metanephric glomerular capillary formation,multicellular organismal development,negative regulation of platelet activation,nucleotide binding,nucleus,odontogenesis of dentin-containing tooth,palate development,peptidyl-tyrosine phosphorylation,phosphatidylinositol 3-kinase binding,phosphatidylinositol-mediated signaling,plasma membrane,platelet aggregation,platelet-derived growth factor alpha-receptor activity,platelet-derived growth factor binding,platelet-derived growth factor receptor binding,platelet-derived growth factor receptor signaling pathway,platelet-derived growth factor receptor-alpha signaling pathway,positive regulation of DNA replication,positive regulation of ERK1 and ERK2 cascade,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of fibroblast proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,protein autophosphorylation,protein homodimerization activity,protein tyrosine kinase activity,receptor activity,regulation of actin cytoskeleton reorganization,regulation of chemotaxis,regulation of mesenchymal stem cell differentiation,response to cytokine stimulus,response to estradiol stimulus,response to hormone stimulus,response to hyperoxia,response to inorganic substance,retina vasculature development in camera-type eye,signal transduction involved in regulation of gene expression,transmembrane receptor protein tyrosine kinase activity,vascular endothelial growth factor receptor signaling pathway,vascular endothelial growth factor-activated receptor activity,wound healing	Becaplermin,Imatinib,Pazopanib,Sunitinib		0.00001	28434.3	GCCCAGATGGACATGA=0, G=0, GCCCGGATGGACATGA=1957		GCCCAGATGGACATGA=0/0, G=0/0, GCCCGGATGGACATGA=943/1014	3,1	
chr5:1294086	C/T	C	SNV		TERT	exonic	1								53.61	p.(=)		1580	C=0.4639, T=0.5361		Present				-	2	NM_198253.2	c.915G>A	synonymous	-1.35					rs2736098		0.213 (ref)	0.2597	0.1051	0.2075	YES	DNA binding,DNA strand elongation,PML body,anti-apoptosis,chromosome,chromosome, telomeric region,cytoplasm,metal ion binding,nuclear telomere cap complex,nucleolus,nucleoplasm,nucleotidyltransferase activity,nucleus,protein binding,protein homodimerization activity,replicative senescence,telomerase activity,telomerase holoenzyme complex,telomere formation via telomerase,telomere maintenance,telomere maintenance via telomerase,telomeric DNA binding,telomeric RNA binding,telomeric template RNA reverse transcriptase activity,transferase activity		non-pathogenic	0.00001	8278.47	C=733, T=847		C=335/398, T=404/443	3	
chr5:38955796	G/A	G	SNV		RICTOR	exonic	1								56.80	p.Ser837Phe		1727	G=0.432, A=0.568		Present				-	26	NM_152756.4	c.2510C>T	missense	1.26	0.7	155.0	0.002		rs2043112		0.392 (ref)	0.401	0.2853	0.3618	YES	T cell costimulation,TORC2 complex,actin cytoskeleton reorganization,cytosol,embryo development,fibroblast growth factor receptor signaling pathway,nerve growth factor receptor signaling pathway,phosphatidylinositol-mediated signaling,positive regulation of TOR signaling cascade,positive regulation of actin filament polymerization,positive regulation of peptidyl-tyrosine phosphorylation,protein binding,regulation of Rac GTPase activity,regulation of actin cytoskeleton organization,regulation of protein kinase B signaling cascade,ribosome binding			0.00001	9911.01	G=746, A=981		G=371/375, A=510/471	2	
chr5:67575548	T/C	T	SNV		PIK3R1	exonic	1								67.73	p.(=)		1999	T=0.3227, C=0.6773		Present				+	5	NM_181523.2	c.621T>C	synonymous	-0.06				RhoGAP domain,SH2 domain,SH3 domain	rs61749601		0.016 (ref)	0.0415	0.0064	0.0296	YES	1-phosphatidylinositol binding,1-phosphatidylinositol-4-phosphate 3-kinase, class IA complex,ErbB-3 class receptor binding,T cell costimulation,T cell receptor signaling pathway,blood coagulation,cytosol,epidermal growth factor receptor signaling pathway,fibroblast growth factor receptor signaling pathway,growth hormone receptor signaling pathway,insulin binding,insulin receptor binding,insulin receptor signaling pathway,insulin receptor substrate binding,insulin-like growth factor receptor binding,insulin-like growth factor receptor signaling pathway,interspecies interaction between organisms,intracellular,leukocyte migration,nerve growth factor receptor signaling pathway,neurotrophin TRKA receptor binding,phosphatidylinositol 3-kinase cascade,phosphatidylinositol 3-kinase regulator activity,phosphatidylinositol phosphorylation,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,phosphatidylinositol-mediated signaling,platelet activation,positive regulation of establishment of protein localization in plasma membrane,positive regulation of glucose import,protein binding,protein phosphatase binding,signal transduction	(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-(METHYLOXY)METHYL-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO4,3,2-DEINDENO4,5-H2BENZOPYRAN-11-YL ACETATE,Isoproterenol		0.00001	15320.1	T=645, C=1354		T=251/394, C=561/793	3	
chr5:176516631	G/A	G	SNV		FGFR4	exonic	1								28.89	p.Val10Ile		1229	G=0.7111, A=0.2889		Present				+	2	NM_213647.1	c.28G>A	missense	-0.41	0.35	29.0	0.0	Immunoglobulin I-set domain,Immunoglobulin V-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs1966265		0.249 (ref)	0.227	0.0611	0.1708	YES	ATP binding,alveolar secondary septum development,cell migration,cell-cell junction,cytoplasm,endoplasmic reticulum,endosome,extracellular region,fibroblast growth factor 1 binding,fibroblast growth factor 2 binding,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,glucose homeostasis,heparin binding,insulin receptor signaling pathway,integral to plasma membrane,lung development,nucleolus,nucleotide binding,nucleus,organ induction,peptidyl-tyrosine phosphorylation,phosphate ion homeostasis,plasma membrane,positive regulation of DNA biosynthetic process,positive regulation of ERK1 and ERK2 cascade,positive regulation of cell proliferation,positive regulation of metalloenzyme activity,positive regulation of proteolysis,protein autophosphorylation,protein tyrosine kinase activity,receptor activity,regulation of bile acid biosynthetic process,regulation of cholesterol homeostasis,regulation of extracellular matrix disassembly,regulation of lipid metabolic process	Palifermin		0.00001	2338.41	G=874, A=355		G=424/450, A=163/192	5	
chr6:41903782	C/C	A	SNV		CCND3	exonic	1								100.00	p.Ser259Ala		1633	A=0.0, C=1.0		Present				-	5	NM_001760.4	c.775T>G	missense	-0.25	0.59	99.0	0.0	Cyclin	rs1051130		0.415 (ref)	0.4535	0.2238	0.3757	YES	T cell proliferation,cell division,cyclin-dependent protein kinase activity,cyclin-dependent protein kinase holoenzyme complex,cytoplasm,membrane,nucleus,positive regulation of cyclin-dependent protein kinase activity,positive regulation of protein phosphorylation,protein binding,protein kinase binding,regulation of cell cycle,signal transduction			0.00001	24881.0	A=0, C=1633		A=0/0, C=791/842	1	
chr6:152129077	T/C	T	SNV		ESR1	exonic	1								27.77	p.(=)		767	T=0.7223, C=0.2777		Present				+	2	NM_001122740.1	c.30T>C	synonymous	-1.28				Ligand-binding domain of nuclear hormone receptor,Oestrogen receptor,Zinc finger	rs2077647		0.432 (ref)	0.4769	0.4828	0.4789	YES	Sertoli cell proliferation,T-tubule,androgen metabolic process,antral ovarian follicle growth,beta-catenin binding,cellular response to estrogen stimulus,chromatin binding,chromatin remodeling complex,cytoplasm,enzyme binding,epithelial cell development,epithelial cell proliferation involved in mammary gland duct elongation,estrogen receptor activity,estrogen response element binding,gene expression,hormone binding,intracellular estrogen receptor signaling pathway,mammary gland alveolus development,mammary gland branching involved in pregnancy,membrane,metal ion binding,mitochondrial part,neuron projection,neuroprotection,nitric-oxide synthase regulator activity,nucleoplasm,nucleus,osteoblast development,perikaryon,perinuclear region of cytoplasm,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of epidermal growth factor receptor signaling pathway,positive regulation of fibroblast proliferation,positive regulation of retinoic acid receptor signaling pathway,positive regulation of survival gene product expression,positive regulation of transcription from RNA polymerase II promoter,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,prostate epithelial cord elongation,protein binding,protein complex binding,receptor activity,regulation of apoptotic process,regulation of branching involved in prostate gland morphogenesis,regulation of transcription, DNA-dependent,response to estradiol stimulus,response to estrogen stimulus,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,signal transduction,steroid binding,steroid hormone mediated signaling pathway,steroid hormone receptor activity,terminal button,transcription factor binding,transcription, DNA-dependent,type 1 metabotropic glutamate receptor binding,uterus development,vagina development,zinc ion binding	(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-4-(2-PYRROLIDIN-1-YLETHOXY)PHENYLCHROMAN-6-OL,(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-9-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(9ALPHA,13BETA,17BETA)-2-(1Z)-BUT-1-EN-1-YLESTRA-1,3,5(10)-TRIENE-3,17-DIOL,(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL,1-4-(Octahydro-Pyrido1,2-aPyrazin-2-Yl)-Phenyl-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,2-AMINO-1-METHYL-6-PHENYLIMIDAZO4,5-BPYRIDINE,2-Phenyl-1-4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol,3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,4-(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(2-amino-1-methyl-1H-imidazo4,5-bpyridin-6-yl)phenol,4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL,4-1-allyl-7-(trifluoromethyl)-1H-indazol-3-ylbenzene-1,3-diol,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YLACETONITRILE,Allylestrenol,Chlorotrianisene,Clomifene,Compound 18,Compound 19,Compound 4-D,Conjugated Estrogens,DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO2.2.1HEPT-5-ENE-2,3-DICARBOXYLATE,Danazol,Desogestrel,Dienestrol,Diethylstilbestrol,Estradiol,Estramustine,Estriol,Estrone,Estropipate,Ethinyl Estradiol,Ethynodiol Diacetate,Etonogestrel,Fluoxymesterone,Fulvestrant,Genistein,Levonorgestrel,Medroxyprogesterone,Melatonin,Mestranol,N-(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE,Naloxone,Norgestimate,Progesterone,Quinestrol,RALOXIFENE CORE,Raloxifene,Tamoxifen,Toremifene,Trilostane,dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo2.2.1hepta-2,5-diene-2,3-dicarboxylate		0.00001	1359.89	T=554, C=213		T=300/254, C=122/91	1	
chr6:152201875	C/C	T	SNV		ESR1	exonic	1								100.00	p.(=)		1996	T=0.0, C=1.0		Present				+	4	NM_001122740.1	c.729T>C	synonymous	0.22				Ligand-binding domain of nuclear hormone receptor,Oestrogen receptor,Zinc finger	rs4986934		0.018 (ref)	0.04	0.0082	0.0292	YES	Sertoli cell proliferation,T-tubule,androgen metabolic process,antral ovarian follicle growth,beta-catenin binding,cellular response to estrogen stimulus,chromatin binding,chromatin remodeling complex,cytoplasm,enzyme binding,epithelial cell development,epithelial cell proliferation involved in mammary gland duct elongation,estrogen receptor activity,estrogen response element binding,gene expression,hormone binding,intracellular estrogen receptor signaling pathway,mammary gland alveolus development,mammary gland branching involved in pregnancy,membrane,metal ion binding,mitochondrial part,neuron projection,neuroprotection,nitric-oxide synthase regulator activity,nucleoplasm,nucleus,osteoblast development,perikaryon,perinuclear region of cytoplasm,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of epidermal growth factor receptor signaling pathway,positive regulation of fibroblast proliferation,positive regulation of retinoic acid receptor signaling pathway,positive regulation of survival gene product expression,positive regulation of transcription from RNA polymerase II promoter,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,prostate epithelial cord elongation,protein binding,protein complex binding,receptor activity,regulation of apoptotic process,regulation of branching involved in prostate gland morphogenesis,regulation of transcription, DNA-dependent,response to estradiol stimulus,response to estrogen stimulus,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,signal transduction,steroid binding,steroid hormone mediated signaling pathway,steroid hormone receptor activity,terminal button,transcription factor binding,transcription, DNA-dependent,type 1 metabotropic glutamate receptor binding,uterus development,vagina development,zinc ion binding	(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-4-(2-PYRROLIDIN-1-YLETHOXY)PHENYLCHROMAN-6-OL,(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-9-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(9ALPHA,13BETA,17BETA)-2-(1Z)-BUT-1-EN-1-YLESTRA-1,3,5(10)-TRIENE-3,17-DIOL,(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL,1-4-(Octahydro-Pyrido1,2-aPyrazin-2-Yl)-Phenyl-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,2-AMINO-1-METHYL-6-PHENYLIMIDAZO4,5-BPYRIDINE,2-Phenyl-1-4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol,3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,4-(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(2-amino-1-methyl-1H-imidazo4,5-bpyridin-6-yl)phenol,4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL,4-1-allyl-7-(trifluoromethyl)-1H-indazol-3-ylbenzene-1,3-diol,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YLACETONITRILE,Allylestrenol,Chlorotrianisene,Clomifene,Compound 18,Compound 19,Compound 4-D,Conjugated Estrogens,DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO2.2.1HEPT-5-ENE-2,3-DICARBOXYLATE,Danazol,Desogestrel,Dienestrol,Diethylstilbestrol,Estradiol,Estramustine,Estriol,Estrone,Estropipate,Ethinyl Estradiol,Ethynodiol Diacetate,Etonogestrel,Fluoxymesterone,Fulvestrant,Genistein,Levonorgestrel,Medroxyprogesterone,Melatonin,Mestranol,N-(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE,Naloxone,Norgestimate,Progesterone,Quinestrol,RALOXIFENE CORE,Raloxifene,Tamoxifen,Toremifene,Trilostane,dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo2.2.1hepta-2,5-diene-2,3-dicarboxylate		0.00001	30358.3	T=0, C=1996		T=0/0, C=943/1053	1	
chr6:152265522	G/C	G	SNV		ESR1	exonic	1								71.47	p.(=)		1991	G=0.2853, C=0.7147		Present				+	5	NM_001122740.1	c.975G>C	synonymous	-0.42				Ligand-binding domain of nuclear hormone receptor,Oestrogen receptor,Zinc finger	rs1801132		0.262 (ref)	0.2257	0.1074	0.1856	YES	Sertoli cell proliferation,T-tubule,androgen metabolic process,antral ovarian follicle growth,beta-catenin binding,cellular response to estrogen stimulus,chromatin binding,chromatin remodeling complex,cytoplasm,enzyme binding,epithelial cell development,epithelial cell proliferation involved in mammary gland duct elongation,estrogen receptor activity,estrogen response element binding,gene expression,hormone binding,intracellular estrogen receptor signaling pathway,mammary gland alveolus development,mammary gland branching involved in pregnancy,membrane,metal ion binding,mitochondrial part,neuron projection,neuroprotection,nitric-oxide synthase regulator activity,nucleoplasm,nucleus,osteoblast development,perikaryon,perinuclear region of cytoplasm,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of epidermal growth factor receptor signaling pathway,positive regulation of fibroblast proliferation,positive regulation of retinoic acid receptor signaling pathway,positive regulation of survival gene product expression,positive regulation of transcription from RNA polymerase II promoter,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,prostate epithelial cord elongation,protein binding,protein complex binding,receptor activity,regulation of apoptotic process,regulation of branching involved in prostate gland morphogenesis,regulation of transcription, DNA-dependent,response to estradiol stimulus,response to estrogen stimulus,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,signal transduction,steroid binding,steroid hormone mediated signaling pathway,steroid hormone receptor activity,terminal button,transcription factor binding,transcription, DNA-dependent,type 1 metabotropic glutamate receptor binding,uterus development,vagina development,zinc ion binding	(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-4-(2-PYRROLIDIN-1-YLETHOXY)PHENYLCHROMAN-6-OL,(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-9-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(9ALPHA,13BETA,17BETA)-2-(1Z)-BUT-1-EN-1-YLESTRA-1,3,5(10)-TRIENE-3,17-DIOL,(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL,1-4-(Octahydro-Pyrido1,2-aPyrazin-2-Yl)-Phenyl-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,2-AMINO-1-METHYL-6-PHENYLIMIDAZO4,5-BPYRIDINE,2-Phenyl-1-4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol,3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,4-(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(2-amino-1-methyl-1H-imidazo4,5-bpyridin-6-yl)phenol,4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL,4-1-allyl-7-(trifluoromethyl)-1H-indazol-3-ylbenzene-1,3-diol,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YLACETONITRILE,Allylestrenol,Chlorotrianisene,Clomifene,Compound 18,Compound 19,Compound 4-D,Conjugated Estrogens,DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO2.2.1HEPT-5-ENE-2,3-DICARBOXYLATE,Danazol,Desogestrel,Dienestrol,Diethylstilbestrol,Estradiol,Estramustine,Estriol,Estrone,Estropipate,Ethinyl Estradiol,Ethynodiol Diacetate,Etonogestrel,Fluoxymesterone,Fulvestrant,Genistein,Levonorgestrel,Medroxyprogesterone,Melatonin,Mestranol,N-(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE,Naloxone,Norgestimate,Progesterone,Quinestrol,RALOXIFENE CORE,Raloxifene,Tamoxifen,Toremifene,Trilostane,dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo2.2.1hepta-2,5-diene-2,3-dicarboxylate		0.00001	16208.6	G=568, C=1423		G=296/272, C=752/671	1	
chr7:6026775	C/C	T	SNV		PMS2	exonic	1								100.00	p.Lys541Glu		1984	T=0.0, C=1.0		Present				-	11	NM_000535.5	c.1621A>G	missense	0.74	1.0	56.0	0.0	DNA mismatch repair protein,Histidine kinase-	rs2228006		0.121 (ref)	0.1543	0.0815	0.1296	YES	ATP binding,ATP catabolic process,ATPase activity,DNA binding,MutLalpha complex,MutSalpha complex binding,endonuclease activity,hydrolase activity,mismatch repair,mismatched DNA binding,nucleus,protein binding,reciprocal meiotic recombination,response to drug,single base insertion or deletion binding,single-stranded DNA binding,somatic hypermutation of immunoglobulin genes,somatic recombination of immunoglobulin gene segments	Adenosine-5'-Diphosphate,Phosphothiophosphoric Acid-Adenylate Ester		0.00001	29945.4	T=0, C=1984		T=0/0, C=1019/965	4	
chr7:6026942	G/T	G	SNV		PMS2	exonic	1								42.01	p.Thr485Lys		1997	G=0.5799, T=0.4201		Present				-	11	NM_000535.5	c.1454C>A	missense	-1.91	0.9	78.0	0.0	DNA mismatch repair protein,Histidine kinase-	rs1805323		0.113 (ref)	0.0407	0.0195	0.0335	YES	ATP binding,ATP catabolic process,ATPase activity,DNA binding,MutLalpha complex,MutSalpha complex binding,endonuclease activity,hydrolase activity,mismatch repair,mismatched DNA binding,nucleus,protein binding,reciprocal meiotic recombination,response to drug,single base insertion or deletion binding,single-stranded DNA binding,somatic hypermutation of immunoglobulin genes,somatic recombination of immunoglobulin gene segments	Adenosine-5'-Diphosphate,Phosphothiophosphoric Acid-Adenylate Ester		0.00001	7053.32	G=1158, T=839		G=603/555, T=434/405	1	
chr7:6036980	C/C	G	SNV		PMS2	exonic	1								100.00	p.(=)		1990	G=0.0, C=1.0		Present				-	7	NM_000535.5	c.780C>G	synonymous	-5.63				DNA mismatch repair protein,Histidine kinase-	rs1805319		0.157 (ref)	0.1852	0.1586	0.1762	YES	ATP binding,ATP catabolic process,ATPase activity,DNA binding,MutLalpha complex,MutSalpha complex binding,endonuclease activity,hydrolase activity,mismatch repair,mismatched DNA binding,nucleus,protein binding,reciprocal meiotic recombination,response to drug,single base insertion or deletion binding,single-stranded DNA binding,somatic hypermutation of immunoglobulin genes,somatic recombination of immunoglobulin gene segments	Adenosine-5'-Diphosphate,Phosphothiophosphoric Acid-Adenylate Ester	non-pathogenic	0.00001	30226.8	G=0, C=1990		G=0/0, C=1115/875	2	
chr7:55211181		G	GENE_EXPRESSION		EGFR								EGFR-EGFR.E3E5				47				Present			2.0677e-11																						0.0					
chr7:55220357		G	GENE_EXPRESSION		EGFR								EGFR.E6E7				20390				Present			8.9703e-09																						0.0					
chr7:55228031		A	GENE_EXPRESSION		EGFR								EGFR-EGFR.E13E15.vII				34				Present			1.4958e-11																						0.0					
chr7:55249063	A/A	G	SNV		EGFR,EGFR-AS1	exonic, exonic_nc	1								100.00	p.(=)		1681	G=0.0, A=1.0		Present				+, -	20	NM_005228.3, NR_047551.1	c.2361G>A	synonymous	2.8				Furin-like cysteine rich region,Protein kinase domain,Protein tyrosine kinase,Receptor L domain	rs1050171		0.418 (ref)	0.3962	0.4226	0.4576	YES	AP-2 adaptor complex,ATP binding,Golgi apparatus,Golgi membrane,MAP/ERK kinase kinase activity,Shc-EGFR complex,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,activation of phospholipase C activity,axon guidance,basolateral plasma membrane,cell morphogenesis,cell proliferation,cell surface receptor linked signaling pathway,cell-cell adhesion,cerebral cortex cell migration,cytoplasm,digestive tract morphogenesis,double-stranded DNA binding,embryonic placenta development,endocytic vesicle,endoplasmic reticulum,endoplasmic reticulum membrane,endosome,endosome membrane,enzyme binding,epidermal growth factor receptor signaling pathway,epidermal growth factor-activated receptor activity,extracellular region,extracellular space,hair follicle development,identical protein binding,integral to membrane,intracellular,membrane,membrane raft,morphogenesis of an epithelial fold,multicellular organismal development,negative regulation of apoptotic process,negative regulation of epidermal growth factor receptor signaling pathway,negative regulation of protein catabolic process,nitric-oxide synthase regulator activity,nuclear membrane,nucleotide binding,nucleus,ossification,perinuclear region of cytoplasm,plasma membrane,positive regulation of DNA repair,positive regulation of DNA replication,positive regulation of MAP kinase activity,positive regulation of catenin import into nucleus,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of cyclin-dependent protein kinase activity involved in G1/S,positive regulation of epithelial cell proliferation,positive regulation of fibroblast proliferation,positive regulation of nitric oxide biosynthetic process,positive regulation of phosphorylation,positive regulation of protein kinase B signaling cascade,protein autophosphorylation,protein binding,protein heterodimerization activity,protein insertion into membrane,protein phosphatase binding,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of nitric-oxide synthase activity,regulation of peptidyl-tyrosine phosphorylation,response to UV-A,response to stress,salivary gland morphogenesis,signal transducer activity,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane signaling receptor activity	Cetuximab,Erlotinib,Flavopiridol,Gefitinib,Lapatinib,Lidocaine,N-4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL-ACRYLAMIDE,Panitumumab,S-{3-(4-ANILINOQUINAZOLIN-6-YL)AMINO-3-OXOPROPYL}-L-CYSTEINE,Trastuzumab,ZD-6474		0.00001	25445.3	G=0, A=1681		G=0/0, A=883/798	1	
chr7:55266417	C/C	T	SNV		EGFR	exonic	1								100.00	p.(=)		1992	T=0.0, C=1.0		Present				+	23	NM_005228.3	c.2709T>C	synonymous	-1.92				Furin-like cysteine rich region,Protein kinase domain,Protein tyrosine kinase,Receptor L domain	rs1140475		0.095 (ref)	0.1267	0.0801	0.1109	YES	AP-2 adaptor complex,ATP binding,Golgi apparatus,Golgi membrane,MAP/ERK kinase kinase activity,Shc-EGFR complex,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,activation of phospholipase C activity,axon guidance,basolateral plasma membrane,cell morphogenesis,cell proliferation,cell surface receptor linked signaling pathway,cell-cell adhesion,cerebral cortex cell migration,cytoplasm,digestive tract morphogenesis,double-stranded DNA binding,embryonic placenta development,endocytic vesicle,endoplasmic reticulum,endoplasmic reticulum membrane,endosome,endosome membrane,enzyme binding,epidermal growth factor receptor signaling pathway,epidermal growth factor-activated receptor activity,extracellular region,extracellular space,hair follicle development,identical protein binding,integral to membrane,intracellular,membrane,membrane raft,morphogenesis of an epithelial fold,multicellular organismal development,negative regulation of apoptotic process,negative regulation of epidermal growth factor receptor signaling pathway,negative regulation of protein catabolic process,nitric-oxide synthase regulator activity,nuclear membrane,nucleotide binding,nucleus,ossification,perinuclear region of cytoplasm,plasma membrane,positive regulation of DNA repair,positive regulation of DNA replication,positive regulation of MAP kinase activity,positive regulation of catenin import into nucleus,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of cyclin-dependent protein kinase activity involved in G1/S,positive regulation of epithelial cell proliferation,positive regulation of fibroblast proliferation,positive regulation of nitric oxide biosynthetic process,positive regulation of phosphorylation,positive regulation of protein kinase B signaling cascade,protein autophosphorylation,protein binding,protein heterodimerization activity,protein insertion into membrane,protein phosphatase binding,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of nitric-oxide synthase activity,regulation of peptidyl-tyrosine phosphorylation,response to UV-A,response to stress,salivary gland morphogenesis,signal transducer activity,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane signaling receptor activity	Cetuximab,Erlotinib,Flavopiridol,Gefitinib,Lapatinib,Lidocaine,N-4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL-ACRYLAMIDE,Panitumumab,S-{3-(4-ANILINOQUINAZOLIN-6-YL)AMINO-3-OXOPROPYL}-L-CYSTEINE,Trastuzumab,ZD-6474		0.00001	30312.8	T=0, C=1992		T=0/0, C=1086/906	1	
chr7:55268106		G	GENE_EXPRESSION		EGFR								EGFR-EGFR.E24E28				10269				Present			4.5177e-09																						0.0					
chr7:55269048		G	GENE_EXPRESSION		EGFR								EGFR-EGFR.E25E18.KDD				22350				Present			9.8325e-09																						0.0					
chr7:55269475		G	GENE_EXPRESSION		EGFR								EGFR.E26E27				10035				Present			4.4147e-09																						0.0					
chr7:116395569		C	GENE_EXPRESSION		MET								MET.E7E8				21637				Present			9.5189e-09																						0.0					
chr7:116415165		G	GENE_EXPRESSION		MET								MET.E15E16				10835				Present			4.7667e-09																						0.0					
chr7:140439646		T	GENE_EXPRESSION		BRAF								BRAF.E16E17				21770				Present			9.5774e-09																						0.0					
chr7:140501300		C	GENE_EXPRESSION		BRAF								BRAF.E5E6				1476				Present			6.4934e-10																						0.0					
chr9:98209594	G/A	G	SNV		PTCH1	exonic	1								50.00	p.Pro1315Leu		892	G=0.5, A=0.5		Present				-	23	NM_000264.3	c.3944C>T	missense	2.51	0.0	98.0	0.906	Patched family	rs357564		0.382 (ref)	0.3298	0.2389	0.2993	YES	Golgi apparatus,brain development,branching involved in ureteric bud morphogenesis,caveola,cell differentiation involved in kidney development,cell proliferation involved in metanephros development,cellular response to cholesterol,cholesterol binding,cyclin binding,dorsal/ventral neural tube patterning,dorsal/ventral pattern formation,embryonic limb morphogenesis,epidermis development,glucose homeostasis,heart morphogenesis,hedgehog family protein binding,heparin binding,hindlimb morphogenesis,integral to plasma membrane,intracellular membrane-bounded organelle,keratinocyte proliferation,limb morphogenesis,mammary gland development,mammary gland duct morphogenesis,mammary gland epithelial cell differentiation,midbody,negative regulation of epithelial cell proliferation,negative regulation of multicellular organism growth,negative regulation of osteoblast differentiation,negative regulation of sequence-specific DNA binding transcription factor activity,negative regulation of smoothened signaling pathway,negative regulation of transcription from RNA polymerase II promoter,neural plate axis specification,neural tube closure,neural tube formation,neural tube patterning,organ morphogenesis,patched binding,pattern specification process,perinuclear region of cytoplasm,pharyngeal system development,plasma membrane,positive regulation of cholesterol efflux,protein binding,protein processing,protein targeting to plasma membrane,receptor activity,regulation of growth,regulation of mitotic cell cycle,regulation of protein localization,regulation of smoothened signaling pathway,renal system development,response to chlorate,signal transduction,smoothened binding,smoothened signaling pathway,somite development			0.00001	4160.32	G=446, A=446		G=226/220, A=183/263	6	
chr9:98229389	C/G	C	SNV		LOC100507346,PTCH1	intronic, exonic_nc	1								46.74			1733	C=0.5326, G=0.4674		Present				-, +		NM_000264.3, NR_038982.1			-0.28				Patched family	rs2066829		0.399 (ref)	0.3645	0.3715	0.4539	YES	Golgi apparatus,brain development,branching involved in ureteric bud morphogenesis,caveola,cell differentiation involved in kidney development,cell proliferation involved in metanephros development,cellular response to cholesterol,cholesterol binding,cyclin binding,dorsal/ventral neural tube patterning,dorsal/ventral pattern formation,embryonic limb morphogenesis,epidermis development,glucose homeostasis,heart morphogenesis,hedgehog family protein binding,heparin binding,hindlimb morphogenesis,integral to plasma membrane,intracellular membrane-bounded organelle,keratinocyte proliferation,limb morphogenesis,mammary gland development,mammary gland duct morphogenesis,mammary gland epithelial cell differentiation,midbody,negative regulation of epithelial cell proliferation,negative regulation of multicellular organism growth,negative regulation of osteoblast differentiation,negative regulation of sequence-specific DNA binding transcription factor activity,negative regulation of smoothened signaling pathway,negative regulation of transcription from RNA polymerase II promoter,neural plate axis specification,neural tube closure,neural tube formation,neural tube patterning,organ morphogenesis,patched binding,pattern specification process,perinuclear region of cytoplasm,pharyngeal system development,plasma membrane,positive regulation of cholesterol efflux,protein binding,protein processing,protein targeting to plasma membrane,receptor activity,regulation of growth,regulation of mitotic cell cycle,regulation of protein localization,regulation of smoothened signaling pathway,renal system development,response to chlorate,signal transduction,smoothened binding,smoothened signaling pathway,somite development			0.00001	7267.46	C=923, G=810		C=500/423, G=404/406	2	
chr9:98238358	G/A	G	SNV		PTCH1	exonic	1								49.22	p.(=)		709	G=0.5078, A=0.4922		Present				-	12	NM_000264.3	c.1686C>T	synonymous	-3.02				Patched family	rs2066836		0.109 (ref)	0.2213	0.0331	0.1575	YES	Golgi apparatus,brain development,branching involved in ureteric bud morphogenesis,caveola,cell differentiation involved in kidney development,cell proliferation involved in metanephros development,cellular response to cholesterol,cholesterol binding,cyclin binding,dorsal/ventral neural tube patterning,dorsal/ventral pattern formation,embryonic limb morphogenesis,epidermis development,glucose homeostasis,heart morphogenesis,hedgehog family protein binding,heparin binding,hindlimb morphogenesis,integral to plasma membrane,intracellular membrane-bounded organelle,keratinocyte proliferation,limb morphogenesis,mammary gland development,mammary gland duct morphogenesis,mammary gland epithelial cell differentiation,midbody,negative regulation of epithelial cell proliferation,negative regulation of multicellular organism growth,negative regulation of osteoblast differentiation,negative regulation of sequence-specific DNA binding transcription factor activity,negative regulation of smoothened signaling pathway,negative regulation of transcription from RNA polymerase II promoter,neural plate axis specification,neural tube closure,neural tube formation,neural tube patterning,organ morphogenesis,patched binding,pattern specification process,perinuclear region of cytoplasm,pharyngeal system development,plasma membrane,positive regulation of cholesterol efflux,protein binding,protein processing,protein targeting to plasma membrane,receptor activity,regulation of growth,regulation of mitotic cell cycle,regulation of protein localization,regulation of smoothened signaling pathway,renal system development,response to chlorate,signal transduction,smoothened binding,smoothened signaling pathway,somite development			0.00001	3244.29	G=360, A=349		G=168/192, A=171/178	2	
chr9:98244242	T/C	T	SNV		PTCH1	exonic	1								45.87	p.(=)		1999	T=0.5413, C=0.4587		Present				-	5	NM_000264.3	c.735A>G	synonymous	-0.32				Patched family	rs1805154		0.011 (ref)	0.0383	0.0068	0.0276	YES	Golgi apparatus,brain development,branching involved in ureteric bud morphogenesis,caveola,cell differentiation involved in kidney development,cell proliferation involved in metanephros development,cellular response to cholesterol,cholesterol binding,cyclin binding,dorsal/ventral neural tube patterning,dorsal/ventral pattern formation,embryonic limb morphogenesis,epidermis development,glucose homeostasis,heart morphogenesis,hedgehog family protein binding,heparin binding,hindlimb morphogenesis,integral to plasma membrane,intracellular membrane-bounded organelle,keratinocyte proliferation,limb morphogenesis,mammary gland development,mammary gland duct morphogenesis,mammary gland epithelial cell differentiation,midbody,negative regulation of epithelial cell proliferation,negative regulation of multicellular organism growth,negative regulation of osteoblast differentiation,negative regulation of sequence-specific DNA binding transcription factor activity,negative regulation of smoothened signaling pathway,negative regulation of transcription from RNA polymerase II promoter,neural plate axis specification,neural tube closure,neural tube formation,neural tube patterning,organ morphogenesis,patched binding,pattern specification process,perinuclear region of cytoplasm,pharyngeal system development,plasma membrane,positive regulation of cholesterol efflux,protein binding,protein processing,protein targeting to plasma membrane,receptor activity,regulation of growth,regulation of mitotic cell cycle,regulation of protein localization,regulation of smoothened signaling pathway,renal system development,response to chlorate,signal transduction,smoothened binding,smoothened signaling pathway,somite development			0.00001	8175.63	T=1082, C=917		T=570/512, C=470/447	1	
chr9:139391636	A/A	G	SNV		NOTCH1	exonic	1								100.00	p.(=)		892	G=0.0, A=1.0		Present				-	34	NM_017617.3	c.6555C>T	synonymous	-0.09				Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,Laminin EGF-like (Domains III and V),NOTCH protein	rs2229974		0.305 (ref)	0.4467	0.3639	0.4187	YES	Golgi apparatus,Golgi lumen,MAML1-RBP-Jkappa- ICN1 complex,Notch receptor processing,Notch signaling pathway,acrosomal vesicle,anagen,aortic valve morphogenesis,axonogenesis,branching morphogenesis of a tube,calcium ion binding,cell differentiation in spinal cord,cell fate specification,chromatin DNA binding,compartment pattern specification,core promoter binding,cytoplasm,cytosol,determination of left/right symmetry,embryo development,embryonic hindlimb morphogenesis,endoderm development,endoplasmic reticulum lumen,extracellular region,forebrain development,foregut morphogenesis,gene expression,hair follicle morphogenesis,heart development,immune response,in utero embryonic development,integral to membrane,liver development,lung development,negative regulation of BMP signaling pathway,negative regulation of apoptotic process,negative regulation of calcium ion-dependent exocytosis,negative regulation of cell death,negative regulation of cell-substrate adhesion,negative regulation of glial cell proliferation,negative regulation of myoblast differentiation,negative regulation of oligodendrocyte differentiation,negative regulation of osteoblast differentiation,negative regulation of photoreceptor cell differentiation,negative regulation of pro-B cell differentiation,negative regulation of stem cell differentiation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,neural tube development,neuron fate commitment,neuronal stem cell maintenance,nucleoplasm,nucleus,organ regeneration,plasma membrane,positive regulation of BMP signaling pathway,positive regulation of JAK-STAT cascade,positive regulation of apoptotic process,positive regulation of astrocyte differentiation,positive regulation of cell proliferation,positive regulation of endothelial cell differentiation,positive regulation of epithelial cell proliferation,positive regulation of epithelial to mesenchymal transition,positive regulation of keratinocyte differentiation,positive regulation of neuroblast proliferation,positive regulation of transcription of Notch receptor target,positive regulation of transcription, DNA-dependent,prostate gland epithelium morphogenesis,protein binding,receptor activity,regulation of cardioblast proliferation,regulation of developmental process,regulation of epithelial cell proliferation involved in prostate gland development,regulation of neurogenesis,regulation of somitogenesis,regulation of transcription, DNA-dependent,response to corticosteroid stimulus,response to lipopolysaccharide,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,somatic stem cell division,spermatogenesis,sprouting angiogenesis,tissue regeneration			0.00001	13458.9	G=0, A=892		G=0/0, A=511/381	1	
chr9:139397707	A/A	G	SNV		NOTCH1	exonic	1								100.00	p.(=)		888	G=0.0, A=1.0		Present				-	27	NM_017617.3	c.5094C>T	synonymous	-0.82				Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,Laminin EGF-like (Domains III and V),NOTCH protein	rs10521		0.417 (ref)	0.3534	0.4829	0.408	YES	Golgi apparatus,Golgi lumen,MAML1-RBP-Jkappa- ICN1 complex,Notch receptor processing,Notch signaling pathway,acrosomal vesicle,anagen,aortic valve morphogenesis,axonogenesis,branching morphogenesis of a tube,calcium ion binding,cell differentiation in spinal cord,cell fate specification,chromatin DNA binding,compartment pattern specification,core promoter binding,cytoplasm,cytosol,determination of left/right symmetry,embryo development,embryonic hindlimb morphogenesis,endoderm development,endoplasmic reticulum lumen,extracellular region,forebrain development,foregut morphogenesis,gene expression,hair follicle morphogenesis,heart development,immune response,in utero embryonic development,integral to membrane,liver development,lung development,negative regulation of BMP signaling pathway,negative regulation of apoptotic process,negative regulation of calcium ion-dependent exocytosis,negative regulation of cell death,negative regulation of cell-substrate adhesion,negative regulation of glial cell proliferation,negative regulation of myoblast differentiation,negative regulation of oligodendrocyte differentiation,negative regulation of osteoblast differentiation,negative regulation of photoreceptor cell differentiation,negative regulation of pro-B cell differentiation,negative regulation of stem cell differentiation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,neural tube development,neuron fate commitment,neuronal stem cell maintenance,nucleoplasm,nucleus,organ regeneration,plasma membrane,positive regulation of BMP signaling pathway,positive regulation of JAK-STAT cascade,positive regulation of apoptotic process,positive regulation of astrocyte differentiation,positive regulation of cell proliferation,positive regulation of endothelial cell differentiation,positive regulation of epithelial cell proliferation,positive regulation of epithelial to mesenchymal transition,positive regulation of keratinocyte differentiation,positive regulation of neuroblast proliferation,positive regulation of transcription of Notch receptor target,positive regulation of transcription, DNA-dependent,prostate gland epithelium morphogenesis,protein binding,receptor activity,regulation of cardioblast proliferation,regulation of developmental process,regulation of epithelial cell proliferation involved in prostate gland development,regulation of neurogenesis,regulation of somitogenesis,regulation of transcription, DNA-dependent,response to corticosteroid stimulus,response to lipopolysaccharide,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,somatic stem cell division,spermatogenesis,sprouting angiogenesis,tissue regeneration			0.00001	13388.5	G=0, A=888		G=0/0, A=518/370	1	
chr9:139407932	A/G	A	SNV		NOTCH1	exonic	1								47.76	p.(=)		1991	A=0.5224, G=0.4776		Present				-	14	NM_017617.3	c.2265T>C	synonymous	-1.25				Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,Laminin EGF-like (Domains III and V),NOTCH protein	rs2229971		0.444 (ref)	0.2858	0.3844	0.3975	YES	Golgi apparatus,Golgi lumen,MAML1-RBP-Jkappa- ICN1 complex,Notch receptor processing,Notch signaling pathway,acrosomal vesicle,anagen,aortic valve morphogenesis,axonogenesis,branching morphogenesis of a tube,calcium ion binding,cell differentiation in spinal cord,cell fate specification,chromatin DNA binding,compartment pattern specification,core promoter binding,cytoplasm,cytosol,determination of left/right symmetry,embryo development,embryonic hindlimb morphogenesis,endoderm development,endoplasmic reticulum lumen,extracellular region,forebrain development,foregut morphogenesis,gene expression,hair follicle morphogenesis,heart development,immune response,in utero embryonic development,integral to membrane,liver development,lung development,negative regulation of BMP signaling pathway,negative regulation of apoptotic process,negative regulation of calcium ion-dependent exocytosis,negative regulation of cell death,negative regulation of cell-substrate adhesion,negative regulation of glial cell proliferation,negative regulation of myoblast differentiation,negative regulation of oligodendrocyte differentiation,negative regulation of osteoblast differentiation,negative regulation of photoreceptor cell differentiation,negative regulation of pro-B cell differentiation,negative regulation of stem cell differentiation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,neural tube development,neuron fate commitment,neuronal stem cell maintenance,nucleoplasm,nucleus,organ regeneration,plasma membrane,positive regulation of BMP signaling pathway,positive regulation of JAK-STAT cascade,positive regulation of apoptotic process,positive regulation of astrocyte differentiation,positive regulation of cell proliferation,positive regulation of endothelial cell differentiation,positive regulation of epithelial cell proliferation,positive regulation of epithelial to mesenchymal transition,positive regulation of keratinocyte differentiation,positive regulation of neuroblast proliferation,positive regulation of transcription of Notch receptor target,positive regulation of transcription, DNA-dependent,prostate gland epithelium morphogenesis,protein binding,receptor activity,regulation of cardioblast proliferation,regulation of developmental process,regulation of epithelial cell proliferation involved in prostate gland development,regulation of neurogenesis,regulation of somitogenesis,regulation of transcription, DNA-dependent,response to corticosteroid stimulus,response to lipopolysaccharide,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,somatic stem cell division,spermatogenesis,sprouting angiogenesis,tissue regeneration			0.00001	8690.91	A=1040, G=951		A=533/507, G=521/430	1	
chr9:139413121	T/C	T	SNV		MIR4673,NOTCH1	exonic, downstream	1								3.38	p.Ser341Gly		1980	T=0.9662, C=0.0338		Present				-	6	NM_017617.3, NR_039820.1	c.1021A>G	missense	1.92	0.51	56.0	0.091	Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,Laminin EGF-like (Domains III and V),NOTCH protein								Golgi apparatus,Golgi lumen,MAML1-RBP-Jkappa- ICN1 complex,Notch receptor processing,Notch signaling pathway,acrosomal vesicle,anagen,aortic valve morphogenesis,axonogenesis,branching morphogenesis of a tube,calcium ion binding,cell differentiation in spinal cord,cell fate specification,chromatin DNA binding,compartment pattern specification,core promoter binding,cytoplasm,cytosol,determination of left/right symmetry,embryo development,embryonic hindlimb morphogenesis,endoderm development,endoplasmic reticulum lumen,extracellular region,forebrain development,foregut morphogenesis,gene expression,hair follicle morphogenesis,heart development,immune response,in utero embryonic development,integral to membrane,liver development,lung development,negative regulation of BMP signaling pathway,negative regulation of apoptotic process,negative regulation of calcium ion-dependent exocytosis,negative regulation of cell death,negative regulation of cell-substrate adhesion,negative regulation of glial cell proliferation,negative regulation of myoblast differentiation,negative regulation of oligodendrocyte differentiation,negative regulation of osteoblast differentiation,negative regulation of photoreceptor cell differentiation,negative regulation of pro-B cell differentiation,negative regulation of stem cell differentiation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,neural tube development,neuron fate commitment,neuronal stem cell maintenance,nucleoplasm,nucleus,organ regeneration,plasma membrane,positive regulation of BMP signaling pathway,positive regulation of JAK-STAT cascade,positive regulation of apoptotic process,positive regulation of astrocyte differentiation,positive regulation of cell proliferation,positive regulation of endothelial cell differentiation,positive regulation of epithelial cell proliferation,positive regulation of epithelial to mesenchymal transition,positive regulation of keratinocyte differentiation,positive regulation of neuroblast proliferation,positive regulation of transcription of Notch receptor target,positive regulation of transcription, DNA-dependent,prostate gland epithelium morphogenesis,protein binding,receptor activity,regulation of cardioblast proliferation,regulation of developmental process,regulation of epithelial cell proliferation involved in prostate gland development,regulation of neurogenesis,regulation of somitogenesis,regulation of transcription, DNA-dependent,response to corticosteroid stimulus,response to lipopolysaccharide,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,somatic stem cell division,spermatogenesis,sprouting angiogenesis,tissue regeneration			0.09686	10.1385	T=1913, C=67		T=881/1032, C=32/35	1	
chr9:139418260	A/G	A	SNV		NOTCH1	exonic	1								48.25	p.(=)		912	A=0.5175, G=0.4825		Present				-	3	NM_017617.3	c.312T>C	synonymous	-1.16				Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,Laminin EGF-like (Domains III and V),NOTCH protein	rs4489420		0.293 (ref)	0.4711	0.1191	0.3913	YES	Golgi apparatus,Golgi lumen,MAML1-RBP-Jkappa- ICN1 complex,Notch receptor processing,Notch signaling pathway,acrosomal vesicle,anagen,aortic valve morphogenesis,axonogenesis,branching morphogenesis of a tube,calcium ion binding,cell differentiation in spinal cord,cell fate specification,chromatin DNA binding,compartment pattern specification,core promoter binding,cytoplasm,cytosol,determination of left/right symmetry,embryo development,embryonic hindlimb morphogenesis,endoderm development,endoplasmic reticulum lumen,extracellular region,forebrain development,foregut morphogenesis,gene expression,hair follicle morphogenesis,heart development,immune response,in utero embryonic development,integral to membrane,liver development,lung development,negative regulation of BMP signaling pathway,negative regulation of apoptotic process,negative regulation of calcium ion-dependent exocytosis,negative regulation of cell death,negative regulation of cell-substrate adhesion,negative regulation of glial cell proliferation,negative regulation of myoblast differentiation,negative regulation of oligodendrocyte differentiation,negative regulation of osteoblast differentiation,negative regulation of photoreceptor cell differentiation,negative regulation of pro-B cell differentiation,negative regulation of stem cell differentiation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,neural tube development,neuron fate commitment,neuronal stem cell maintenance,nucleoplasm,nucleus,organ regeneration,plasma membrane,positive regulation of BMP signaling pathway,positive regulation of JAK-STAT cascade,positive regulation of apoptotic process,positive regulation of astrocyte differentiation,positive regulation of cell proliferation,positive regulation of endothelial cell differentiation,positive regulation of epithelial cell proliferation,positive regulation of epithelial to mesenchymal transition,positive regulation of keratinocyte differentiation,positive regulation of neuroblast proliferation,positive regulation of transcription of Notch receptor target,positive regulation of transcription, DNA-dependent,prostate gland epithelium morphogenesis,protein binding,receptor activity,regulation of cardioblast proliferation,regulation of developmental process,regulation of epithelial cell proliferation involved in prostate gland development,regulation of neurogenesis,regulation of somitogenesis,regulation of transcription, DNA-dependent,response to corticosteroid stimulus,response to lipopolysaccharide,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,somatic stem cell division,spermatogenesis,sprouting angiogenesis,tissue regeneration			0.00001	4048.69	A=472, G=440		A=251/221, G=218/222	1	
chr10:43613843	G/T	G	SNV		RET	exonic	1								35.12	p.(=)		561	G=0.6488, T=0.3512		Present				+	13	NM_020975.4	c.2307G>T	synonymous	1.34				Cadherin domain,Protein kinase domain,Protein tyrosine kinase	rs1800861		0.277 (ref)	0.2347	0.1246	0.1974	YES	ATP binding,MAPKKK cascade,calcium ion binding,cellular response to retinoic acid,embryonic epithelial tube formation,endosome membrane,enteric nervous system development,homophilic cell adhesion,induction of apoptosis,integral to membrane,integral to plasma membrane,membrane,membrane protein proteolysis,nervous system development,neural crest cell migration,neuron maturation,nucleotide binding,positive regulation of cell adhesion mediated by integrin,positive regulation of cell migration,positive regulation of metanephric glomerulus development,positive regulation of neuron projection development,positive regulation of transcription, DNA-dependent,posterior midgut development,protein binding,protein phosphorylation,protein tyrosine kinase activity,receptor activity,regulation of cell adhesion,response to pain,signal transduction,transmembrane receptor protein tyrosine kinase activity,ureteric bud development	1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo3,4-DPyrimidin-4-Ylamine,4-BROMO-2-FLUORO-N-(4E)-6-METHOXY-7-(1-METHYLPIPERIDIN-4-YL)METHOXYQUINAZOLIN-4(1H)-YLIDENEANILINE,Imatinib	untested	0.00001	1457.74	G=364, T=197		G=161/203, T=73/124	1	
chr10:43615633	C/G	C	SNV		RET	exonic	1								29.16	p.(=)		607	C=0.7084, G=0.2916		Present				+	15	NM_020975.4	c.2712C>G	synonymous	0.73				Cadherin domain,Protein kinase domain,Protein tyrosine kinase	rs1800863		0.16 (ref)	0.1866	0.111	0.1609	YES	ATP binding,MAPKKK cascade,calcium ion binding,cellular response to retinoic acid,embryonic epithelial tube formation,endosome membrane,enteric nervous system development,homophilic cell adhesion,induction of apoptosis,integral to membrane,integral to plasma membrane,membrane,membrane protein proteolysis,nervous system development,neural crest cell migration,neuron maturation,nucleotide binding,positive regulation of cell adhesion mediated by integrin,positive regulation of cell migration,positive regulation of metanephric glomerulus development,positive regulation of neuron projection development,positive regulation of transcription, DNA-dependent,posterior midgut development,protein binding,protein phosphorylation,protein tyrosine kinase activity,receptor activity,regulation of cell adhesion,response to pain,signal transduction,transmembrane receptor protein tyrosine kinase activity,ureteric bud development	1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo3,4-DPyrimidin-4-Ylamine,4-BROMO-2-FLUORO-N-(4E)-6-METHOXY-7-(1-METHYLPIPERIDIN-4-YL)METHOXYQUINAZOLIN-4(1H)-YLIDENEANILINE,Imatinib	non-pathogenic	0.00001	1168.96	C=430, G=177		C=193/237, G=78/99	2	
chr10:123298158	C/C	T	SNV		FGFR2	exonic	1								100.00	p.(=)		1650	T=0.0, C=1.0		Present				-	6	NM_000141.4	c.696A>G	synonymous	0.96				Immunoglobulin I-set domain,Immunoglobulin V-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs1047100		0.176 (ref)	0.2236	0.2522	0.2333	YES	ATP binding,Golgi apparatus,angiogenesis,apoptotic process,axonogenesis,bone development,bone mineralization,bone morphogenesis,branch elongation involved in salivary gland morphogenesis,branching involved in embryonic placenta morphogenesis,branching involved in prostate gland morphogenesis,branching involved in salivary gland morphogenesis,branching morphogenesis of a nerve,bud elongation involved in lung branching,cell cortex,cell fate commitment,cell surface,cell-cell signaling,cytoplasm,cytoplasmic membrane-bounded vesicle,digestive tract development,embryonic digestive tract morphogenesis,embryonic organ development,embryonic organ morphogenesis,embryonic pattern specification,epidermis morphogenesis,epithelial cell differentiation,epithelial cell proliferation involved in salivary gland morphogenesis,excitatory synapse,extracellular matrix,extracellular region,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,fibroblast growth factor-activated receptor activity,gland morphogenesis,hair follicle morphogenesis,heparin binding,in utero embryonic development,inner ear morphogenesis,insulin receptor signaling pathway,integral to membrane,integral to plasma membrane,lacrimal gland development,lateral sprouting from an epithelium,limb bud formation,lung alveolus development,lung development,lung lobe morphogenesis,lung-associated mesenchyme development,mammary gland bud formation,membrane,membranous septum morphogenesis,mesenchymal cell differentiation,mesenchymal cell differentiation involved in lung development,mesenchymal cell proliferation involved in lung development,midbrain development,morphogenesis of embryonic epithelium,multicellular organism growth,negative regulation of transcription from RNA polymerase II promoter,nucleotide binding,nucleus,odontogenesis,orbitofrontal cortex development,organ growth,organ morphogenesis,otic vesicle formation,outflow tract septum morphogenesis,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of MAPKKK cascade,positive regulation of Wnt receptor signaling pathway,positive regulation of canonical Wnt receptor signaling pathway,positive regulation of cardiac muscle cell proliferation,positive regulation of cell cycle,positive regulation of cell division,positive regulation of cell proliferation,positive regulation of epithelial cell proliferation,positive regulation of epithelial cell proliferation involved in lung morphogenesis,positive regulation of mesenchymal cell proliferation,positive regulation of phospholipase activity,positive regulation of transcription from RNA polymerase II promoter,post-embryonic development,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,prostate epithelial cord elongation,prostate gland morphogenesis,protein autophosphorylation,protein binding,protein homodimerization activity,protein tyrosine kinase activity,pyramidal neuron development,receptor activity,regulation of ERK1 and ERK2 cascade,regulation of branching involved in prostate gland morphogenesis,regulation of cell fate commitment,regulation of fibroblast growth factor receptor signaling pathway,regulation of morphogenesis of a branching structure,regulation of multicellular organism growth,regulation of osteoblast differentiation,regulation of osteoblast proliferation,regulation of smooth muscle cell differentiation,regulation of smoothened signaling pathway,reproductive structure development,skeletal system morphogenesis,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,ureteric bud development,ventricular cardiac muscle tissue morphogenesis,ventricular zone neuroblast division	4-4-(1-Amino-1-Methylethyl)Phenyl-5-Chloro-N-4-(2-Morpholin-4-Ylethyl)PhenylPyrimidin-2-Amine,Palifermin,SU4984,Thalidomide		0.00001	25045.8	T=0, C=1650		T=0/0, C=868/782	1	
chr11:108183167	G/G	A	SNV		ATM	exonic	1								100.00	p.Asn1983Ser		1687	A=0.0, G=1.0		Present				+	40	NM_000051.3	c.5948A>G	missense	-0.19	1.0	46.0	0.0	FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase	rs659243		0.0 (ref)					1-phosphatidylinositol-3-kinase activity,ATP binding,DNA binding,DNA damage induced protein phosphorylation,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,DNA damage response, signal transduction resulting in induction of apoptosis,DNA repair,DNA-dependent protein kinase activity,G2/M transition DNA damage checkpoint,brain development,cell cycle arrest,cell cycle checkpoint,cell death,cellular response to gamma radiation,chromosome, telomeric region,cytoplasm,cytoplasmic membrane-bounded vesicle,double-strand break repair,double-strand break repair via homologous recombination,female gamete generation,heart development,histone mRNA catabolic process,histone serine kinase activity,lipoprotein catabolic process,mitotic cell cycle spindle assembly checkpoint,negative regulation of B cell proliferation,negative regulation of apoptotic process,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,positive regulation of DNA damage response, signal transduction by p53 class mediator,positive regulation of apoptotic process,positive regulation of neuron apoptosis,pre-B cell allelic exclusion,protein N-terminus binding,protein autophosphorylation,protein binding,protein complex binding,protein dimerization activity,protein serine/threonine kinase activity,reciprocal meiotic recombination,regulation of cell cycle,replicative senescence,response to DNA damage stimulus,response to hypoxia,response to ionizing radiation,signal transduction,somitogenesis,spindle			0.00001	25621.6	A=0, G=1687		A=0/0, G=958/729	2	
chr11:125525195	G/G	A	SNV		CHEK1	exonic	1								100.00	p.Ile471Val		1994	A=0.0, G=1.0		Present				+	13	NM_001274.5	c.1411A>G	missense	0.45	1.0	29.0	0.0	Protein kinase domain,Protein tyrosine kinase	rs506504		0.017 (ref)	0.0363	0.0064	0.0262	YES	ATP binding,DNA damage checkpoint,DNA damage induced protein phosphorylation,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,G2/M transition of mitotic cell cycle,cell cycle,cell cycle checkpoint,cellular response to caffeine,cellular response to mechanical stimulus,cellular response to organic substance,centrosome,chromatin,chromatin-mediated maintenance of transcription,chromosome, telomeric region,condensed nuclear chromosome,cytoplasm,cytoskeleton,histone H3-T11 phosphorylation,histone kinase activity (H3-T11 specific),negative regulation of mitosis,nucleoplasm,nucleotide binding,nucleus,peptidyl-threonine phosphorylation,protein binding,protein serine/threonine kinase activity,regulation of S phase,regulation of double-strand break repair via homologous recombination,regulation of histone H3-K9 acetylation,regulation of mitotic centrosome separation,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,replication fork,replicative senescence,response to DNA damage stimulus	(2R)-1-(5,6-DIPHENYL-7H-PYRROLO2,3-DPYRIMIDIN-4-YL)AMINOPROPAN-2-OL,(2R)-3-{(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO2,3-DPYRIMIDIN-4-YLIDENEAMINO}PROPANE-1,2-DIOL,(2S)-1-AMINO-3-(5-NITROQUINOLIN-8-YL)AMINOPROPAN-2-OL,(3-ENDO)-8-METHYL-8-AZABICYCLO3.2.1OCT-3-YL 1H-PYRROLO2,3-BPYRIDINE-3-CARBOXYLATE,(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE,(5,6-DIPHENYL-FURO2,3-DPYRIMIDIN-4-YLAMINO)-ACETIC,(5-{3-5-(PIPERIDIN-1-YLMETHYL)-1H-INDOL-2-YL-1H-INDAZOL-6-YL}-2H-1,2,3-TRIAZOL-4-YL)METHANOL,1-(2S)-4-(5-BROMO-1H-PYRAZOLO3,4-BPYRIDIN-4-YL)MORPHOLIN-2-YLMETHANAMINE,1-(2S)-4-(5-phenyl-1H-pyrazolo3,4-bpyridin-4-yl)morpholin-2-ylmethanamine,1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA,1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-2-(DIMETHYLAMINO)-1-METHYLETHOXYPYRAZIN-2-YL}UREA,18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE,2,2'-{9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYLBIS(OXY)}DIACETIC ACID,2-(5,6-DIPHENYLFURO2,3-DPYRIMIDIN-4-YL)AMINOETHANOL,2-(cyclohexylamino)benzoic acid,2-(methylsulfanyl)-5-(thiophen-2-ylmethyl)-1H-imidazol-4-ol,2-5,6-BIS-(4-METHOXY-PHENYL)-FURO2,3-DPYRIMIDIN-4-YLAMINO-ETHANOL,3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOLE,3-(5-{4-(AMINOMETHYL)PIPERIDIN-1-YLMETHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE,3-(5-{4-(AMINOMETHYL)PIPERIDIN-1-YLMETHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE,3-AMINO-3-BENZYL-4.3.0BICYCLO-1,6-DIAZANONAN-2-ONE,4-(3S)-1-AZABICYCLO2.2.2OCT-3-YLAMINO-3-(1H-BENZIMIDAZOL-2-YL)-6-CHLOROQUINOLIN-2(1H)-ONE,4-(6-{(4-METHYLCYCLOHEXYL)AMINOMETHYL}-1,4-DIHYDROINDENO1,2-CPYRAZOL-3-YL)BENZOIC ACID,4-3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOL-6-YL-2-METHOXYPHENOL,4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl(phenyl)methanone,5,6,7,8-TETRAHYDRO1BENZOTHIENO2,3-DPYRIMIDIN-4(3H)-ONE,5-ETHYL-3-METHYL-1,5-DIHYDRO-4H-PYRAZOLO4,3-CQUINOLIN-4-ONE,6-MORPHOLIN-4-YL-9H-PURINE,N-(4-OXO-5,6,7,8-TETRAHYDRO-4H-1,3THIAZOLO5,4-CAZEPIN-2-YL)ACETAMIDE,N-(5,6-DIPHENYLFURO2,3-DPYRIMIDIN-4-YL)GLYCINE,N-{5-4-(4-METHYLPIPERAZIN-1-YL)PHENYL-1H-PYRROLO2,3-BPYRIDIN-3-YL}NICOTINAMIDE,REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO1,2,3-FG:3',2',1'-KLPYRROLO3,4-I1,6BENZODIAZOCINE-1,3(2H)-DIONE		0.00001	30286.1	A=0, G=1994		A=0/0, G=978/1016	1	
chr12:12870853	C/T	C	SNV		CDKN1B	exonic	1								21.75	p.Ser27Leu		2000	C=0.7825, T=0.2175		Present				+	1	NM_004064.4	c.80C>T	missense	2.4	0.01	145.0	1.0	Cyclin-dependent kinase inhibitor								DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,G1 phase of mitotic cell cycle,G1/S transition of mitotic cell cycle,S phase of mitotic cell cycle,activation of caspase activity,autophagic cell death,cell cycle,cell cycle arrest,cell cycle checkpoint,cellular response to antibiotic,cellular response to lithium ion,cellular response to organic cyclic compound,cyclin-dependent protein kinase activity,cyclin-dependent protein kinase inhibitor activity,cysteine-type endopeptidase activator activity involved in apoptotic process,cytoplasm,cytosol,endosome,fibroblast growth factor receptor signaling pathway,induction of apoptosis,inner ear development,kinase activity,mitotic cell cycle,mitotic cell cycle arrest,negative regulation of apoptotic process,negative regulation of cell growth,negative regulation of cell proliferation,negative regulation of cellular component movement,negative regulation of cyclin-dependent protein kinase activity,negative regulation of epithelial cell proliferation involved in prostate gland development,negative regulation of kinase activity,negative regulation of mitotic cell cycle,negative regulation of phosphorylation,negative regulation of transcription, DNA-dependent,nerve growth factor receptor signaling pathway,nucleoplasm,nucleus,phosphatidylinositol-mediated signaling,phosphorylation,positive regulation of cell death,positive regulation of cell proliferation,positive regulation of microtubule polymerization,positive regulation of protein catabolic process,potassium ion transport,protein binding,protein kinase inhibitor activity,protein phosphatase binding,regulation of cyclin-dependent protein kinase activity,sensory perception of sound,transforming growth factor beta receptor, cytoplasmic mediator activity			0.00001	2317.89	C=1565, T=435		C=738/827, T=212/223	1	
chr12:25368462	T/T	C	SNV		KRAS	exonic	1								100.00	p.(=)		1982	C=0.0, T=1.0		Present				-	5	NM_033360.3	c.483G>A	synonymous	1.06				Miro-like protein,Ras family	rs4362222		0.0 (ref)	0.0	0.0043	0.0015		GDP binding,GMP binding,GTP binding,GTPase activity,LRR domain binding,MAPKKK cascade,Ral guanyl-nucleotide exchange factor activity,Ras protein signal transduction,activation of MAPKK activity,axon guidance,blood coagulation,cytokine-mediated signaling pathway,epidermal growth factor receptor signaling pathway,insulin receptor signaling pathway,leukocyte migration,membrane raft,mitochondrion,nerve growth factor receptor signaling pathway,nucleotide binding,plasma membrane,positive regulation of MAP kinase activity,positive regulation of NF-kappaB transcription factor activity,positive regulation of nitric-oxide synthase activity,protein binding,response to glucocorticoid stimulus,response to mineralocorticoid stimulus,signal transduction,small GTPase mediated signal transduction,social behavior	(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL-PHOSPHONIC ACID,FARNESYL,FARNESYL DIPHOSPHATE		0.00001	29871.5	C=0, T=1982		C=0/0, T=947/1035	3	
chr12:25398284	CC/TC	CC	SNV		KRAS	exonic	1	Hotspot	Gain-of-function			HS	COSM520;COSM522;COSM521;COSM512;COSM514;COSM34144;COSM25081;COSM13643		AA=0.00, AC=0.00, AG=0.00, AT=0.00, GC=0.00, TA=0.00, TC=47.64, TT=0.00	p.Gly12Asp		1994	CC=0.5236, AA=0.0, AC=0.0, AG=0.0, AT=0.0, GC=0.0, TA=0.0, TC=0.4764, TT=0.0		Present				-	2	NM_033360.3	c.35G>A	missense	2.67,2.67	0.0	94.0	0.517	Miro-like protein,Ras family	rs121913529,rs121913530							GDP binding,GMP binding,GTP binding,GTPase activity,LRR domain binding,MAPKKK cascade,Ral guanyl-nucleotide exchange factor activity,Ras protein signal transduction,activation of MAPKK activity,axon guidance,blood coagulation,cytokine-mediated signaling pathway,epidermal growth factor receptor signaling pathway,insulin receptor signaling pathway,leukocyte migration,membrane raft,mitochondrion,nerve growth factor receptor signaling pathway,nucleotide binding,plasma membrane,positive regulation of MAP kinase activity,positive regulation of NF-kappaB transcription factor activity,positive regulation of nitric-oxide synthase activity,protein binding,response to glucocorticoid stimulus,response to mineralocorticoid stimulus,signal transduction,small GTPase mediated signal transduction,social behavior	(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL-PHOSPHONIC ACID,FARNESYL,FARNESYL DIPHOSPHATE	other	0.00001	8056.54	CC=1044, AA=0, AC=0, AG=0, AT=0, GC=0, TA=0, TC=950, TT=0		CC=547/497, AA=0/0, AC=0/0, AG=0/0, AT=0/0, GC=0/0, TA=0/0, TC=509/441, TT=0/0	2,2,2,2,2,2,2,2	
chr12:133208979	C/C	T	SNV		POLE	exonic	1								100.00	p.(=)		1056	T=0.0, C=1.0		Present				-	45	NM_006231.3	c.6252A>G	synonymous	-2.14				DNA polymerase family B,Domain of unknown function (DUF1744)	rs5745022		0.307 (ref)	0.4157	0.2433	0.3573	YES	DNA binding,DNA repair,DNA replication,DNA synthesis involved in DNA repair,DNA-dependent DNA replication initiation,DNA-directed DNA polymerase activity,G1/S transition of mitotic cell cycle,M/G1 transition of mitotic cell cycle,S phase of mitotic cell cycle,base-excision repair, gap-filling,chromatin binding,in utero embryonic development,metal ion binding,mitotic cell cycle,nucleobase-containing compound metabolic process,nucleoplasm,nucleotide binding,nucleotide-excision repair,nucleotide-excision repair, DNA gap filling,nucleotidyltransferase activity,nucleus,telomere maintenance,telomere maintenance via recombination,telomere maintenance via semi-conservative replication,transcription-coupled nucleotide-excision repair,transferase activity,zinc ion binding	Cladribine		0.00001	16001.6	T=0, C=1056		T=0/0, C=486/570	1	
chr12:133219831	C/C	T	SNV		POLE	exonic	1								100.00	p.(=)		881	T=0.0, C=1.0		Present				-	35	NM_006231.3	c.4530A>G	synonymous	-2.11				DNA polymerase family B,Domain of unknown function (DUF1744)	rs5744944		0.416 (ref)	0.4306	0.2985	0.4776	YES	DNA binding,DNA repair,DNA replication,DNA synthesis involved in DNA repair,DNA-dependent DNA replication initiation,DNA-directed DNA polymerase activity,G1/S transition of mitotic cell cycle,M/G1 transition of mitotic cell cycle,S phase of mitotic cell cycle,base-excision repair, gap-filling,chromatin binding,in utero embryonic development,metal ion binding,mitotic cell cycle,nucleobase-containing compound metabolic process,nucleoplasm,nucleotide binding,nucleotide-excision repair,nucleotide-excision repair, DNA gap filling,nucleotidyltransferase activity,nucleus,telomere maintenance,telomere maintenance via recombination,telomere maintenance via semi-conservative replication,transcription-coupled nucleotide-excision repair,transferase activity,zinc ion binding	Cladribine		0.00001	13326.9	T=0, C=881		T=0/0, C=398/483	1	
chr12:133236000	T/T	C	SNV		POLE	exonic	1								100.00	p.(=)		1996	C=0.0, T=1.0		Present				-	26	NM_006231.3	c.3156G>A	synonymous	-3.0				DNA polymerase family B,Domain of unknown function (DUF1744)	rs5744857		0.416 (ref)	0.4307	0.2985	0.4775	YES	DNA binding,DNA repair,DNA replication,DNA synthesis involved in DNA repair,DNA-dependent DNA replication initiation,DNA-directed DNA polymerase activity,G1/S transition of mitotic cell cycle,M/G1 transition of mitotic cell cycle,S phase of mitotic cell cycle,base-excision repair, gap-filling,chromatin binding,in utero embryonic development,metal ion binding,mitotic cell cycle,nucleobase-containing compound metabolic process,nucleoplasm,nucleotide binding,nucleotide-excision repair,nucleotide-excision repair, DNA gap filling,nucleotidyltransferase activity,nucleus,telomere maintenance,telomere maintenance via recombination,telomere maintenance via semi-conservative replication,transcription-coupled nucleotide-excision repair,transferase activity,zinc ion binding	Cladribine		0.00001	30346.3	C=0, T=1996		C=0/0, T=919/1077	1	
chr12:133240967	G/A	G	SNV		POLE	exonic	1								34.95	p.(=)		475	G=0.6505, A=0.3495		Present				-	22	NM_006231.3	c.2550C>T	synonymous	-1.95				DNA polymerase family B,Domain of unknown function (DUF1744)	rs5744834		0.01 (ref)	3.0E-4	0.0454	0.0156	YES	DNA binding,DNA repair,DNA replication,DNA synthesis involved in DNA repair,DNA-dependent DNA replication initiation,DNA-directed DNA polymerase activity,G1/S transition of mitotic cell cycle,M/G1 transition of mitotic cell cycle,S phase of mitotic cell cycle,base-excision repair, gap-filling,chromatin binding,in utero embryonic development,metal ion binding,mitotic cell cycle,nucleobase-containing compound metabolic process,nucleoplasm,nucleotide binding,nucleotide-excision repair,nucleotide-excision repair, DNA gap filling,nucleotidyltransferase activity,nucleus,telomere maintenance,telomere maintenance via recombination,telomere maintenance via semi-conservative replication,transcription-coupled nucleotide-excision repair,transferase activity,zinc ion binding	Cladribine		0.00001	1247.67	G=309, A=166		G=149/160, A=86/80	1	
chr13:28636084	A/A	G	SNV		FLT3	exonic	1								100.00	p.(=)		1994	G=0.0, A=1.0		Present				-	3	NM_004119.2	c.288C>T	synonymous	0.04				Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs7338903		0.041 (ref)	0.0105	0.0978	0.0401	YES	ATP binding,cell surface,cellular response to cytokine stimulus,cytokine receptor activity,cytokine-mediated signaling pathway,endoplasmic reticulum,endoplasmic reticulum lumen,hemopoiesis,integral to plasma membrane,lymphocyte differentiation,membrane,myeloid progenitor cell differentiation,negative regulation of B cell differentiation,negative regulation of cell proliferation,nucleotide binding,peptidyl-tyrosine phosphorylation,phosphatidylinositol 3-kinase binding,positive regulation of MAP kinase activity,positive regulation of MAPKKK cascade,positive regulation of cell proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of tyrosine phosphorylation of STAT protein,pro-B cell differentiation,pro-T cell differentiation,protein autophosphorylation,protein homodimerization activity,receptor activity,regulation of apoptotic process,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway,vascular endothelial growth factor receptor signaling pathway,vascular endothelial growth factor-activated receptor activity	Sorafenib,Sunitinib		0.00001	30385.4	G=0, A=1994		G=0/0, A=931/1063	1	
chr13:32899321		G	GENE_EXPRESSION		BRCA2								BRCA2.E5E6				103854				Present			4.5689e-08																						0.0					
chr13:32911888	A/G	A	SNV		BRCA2	exonic	1								35.82	p.(=)		1820	A=0.6418, G=0.3582		Present				+	11	NM_000059.3	c.3396A>G	synonymous	-0.12				BRCA2 repeat	rs1801406		0.279	0.3074	0.2261	0.2798	YES	BRCA2-MAGE-D1 complex,DNA binding,DNA recombination,DNA repair,H3 histone acetyltransferase activity,H4 histone acetyltransferase activity,cell cycle,cell cycle cytokinesis,centrosome,centrosome duplication,cytoplasm,double-strand break repair,double-strand break repair via homologous recombination,gamma-tubulin binding,histone H3 acetylation,histone H4 acetylation,histone acetyltransferase activity,homologous chromosome orientation involved in meiotic metaphase I plate congression,mammary gland development,multicellular organism growth,negative regulation of mammary gland epithelial cell proliferation,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,positive regulation of transcription, DNA-dependent,protease binding,protein binding,protein complex,regulation of S phase of mitotic cell cycle,response to estradiol stimulus,response to nutrient,secretory granule,single-stranded DNA binding,spermatogenesis		untested	0.00001	4954.14	A=1168, G=652		A=583/585, G=324/328	4	
chr13:32913055	G/G	A	SNV		BRCA2	exonic	1								100.00	p.(=)		1994	A=0.0, G=1.0		Present				+	11	NM_000059.3	c.4563A>G	synonymous	0.6				BRCA2 repeat	rs206075		0.026 (ref)	6.0E-4	0.0704	0.0242	YES	BRCA2-MAGE-D1 complex,DNA binding,DNA recombination,DNA repair,H3 histone acetyltransferase activity,H4 histone acetyltransferase activity,cell cycle,cell cycle cytokinesis,centrosome,centrosome duplication,cytoplasm,double-strand break repair,double-strand break repair via homologous recombination,gamma-tubulin binding,histone H3 acetylation,histone H4 acetylation,histone acetyltransferase activity,homologous chromosome orientation involved in meiotic metaphase I plate congression,mammary gland development,multicellular organism growth,negative regulation of mammary gland epithelial cell proliferation,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,positive regulation of transcription, DNA-dependent,protease binding,protein binding,protein complex,regulation of S phase of mitotic cell cycle,response to estradiol stimulus,response to nutrient,secretory granule,single-stranded DNA binding,spermatogenesis			0.00001	30317.1	A=0, G=1994		A=0/0, G=1141/853	1	
chr13:32915005	C/C	G	SNV		BRCA2	exonic	1								100.00	p.(=)		1998	G=0.0, C=1.0		Present				+	11	NM_000059.3	c.6513G>C	synonymous	-1.1				BRCA2 repeat	rs206076		0.026 (ref)	6.0E-4	0.0713	0.0245	YES	BRCA2-MAGE-D1 complex,DNA binding,DNA recombination,DNA repair,H3 histone acetyltransferase activity,H4 histone acetyltransferase activity,cell cycle,cell cycle cytokinesis,centrosome,centrosome duplication,cytoplasm,double-strand break repair,double-strand break repair via homologous recombination,gamma-tubulin binding,histone H3 acetylation,histone H4 acetylation,histone acetyltransferase activity,homologous chromosome orientation involved in meiotic metaphase I plate congression,mammary gland development,multicellular organism growth,negative regulation of mammary gland epithelial cell proliferation,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,positive regulation of transcription, DNA-dependent,protease binding,protein binding,protein complex,regulation of S phase of mitotic cell cycle,response to estradiol stimulus,response to nutrient,secretory granule,single-stranded DNA binding,spermatogenesis			0.00001	30443.8	G=0, C=1998		G=0/0, C=1121/877	1	
chr13:32929232	A/G	A	SNV		BRCA2	exonic	1								35.03	p.(=)		768	A=0.6497, G=0.3503		Present				+	14	NM_000059.3	c.7242A>G	synonymous	-0.13				BRCA2 repeat	rs1799955		0.245 (ref)	0.2133	0.2077	0.2114	YES	BRCA2-MAGE-D1 complex,DNA binding,DNA recombination,DNA repair,H3 histone acetyltransferase activity,H4 histone acetyltransferase activity,cell cycle,cell cycle cytokinesis,centrosome,centrosome duplication,cytoplasm,double-strand break repair,double-strand break repair via homologous recombination,gamma-tubulin binding,histone H3 acetylation,histone H4 acetylation,histone acetyltransferase activity,homologous chromosome orientation involved in meiotic metaphase I plate congression,mammary gland development,multicellular organism growth,negative regulation of mammary gland epithelial cell proliferation,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,positive regulation of transcription, DNA-dependent,protease binding,protein binding,protein complex,regulation of S phase of mitotic cell cycle,response to estradiol stimulus,response to nutrient,secretory granule,single-stranded DNA binding,spermatogenesis		untested	0.00001	2007.3	A=499, G=269		A=245/254, G=127/142	1	
chr13:32929387	C/C	T	SNV		BRCA2	exonic	1								100.00	p.Val2466Ala		1688	T=0.0, C=1.0		Present				+	14	NM_000059.3	c.7397T>C	missense	1.27	0.58	64.0	0.0	BRCA2 repeat	rs169547		0.022 (ref)	6.0E-4	0.0647	0.0223	YES	BRCA2-MAGE-D1 complex,DNA binding,DNA recombination,DNA repair,H3 histone acetyltransferase activity,H4 histone acetyltransferase activity,cell cycle,cell cycle cytokinesis,centrosome,centrosome duplication,cytoplasm,double-strand break repair,double-strand break repair via homologous recombination,gamma-tubulin binding,histone H3 acetylation,histone H4 acetylation,histone acetyltransferase activity,homologous chromosome orientation involved in meiotic metaphase I plate congression,mammary gland development,multicellular organism growth,negative regulation of mammary gland epithelial cell proliferation,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,positive regulation of transcription, DNA-dependent,protease binding,protein binding,protein complex,regulation of S phase of mitotic cell cycle,response to estradiol stimulus,response to nutrient,secretory granule,single-stranded DNA binding,spermatogenesis		untested	0.00001	25507.4	T=0, C=1688		T=0/0, C=829/859	1	
chr13:32937670		G	GENE_EXPRESSION		BRCA2								BRCA2.E18E19				526				Present			2.3141e-10																						0.0					
chr13:48919335		G	GENE_EXPRESSION		RB1								RB1.E4E5				3477				Present			1.5297e-09																						0.0					
chr13:49050979		G	GENE_EXPRESSION		RB1								RB1.E26E27				1874				Present			8.2444e-10																						0.0					
chr14:105239894	C/T	C	SNV		AKT1	exonic	1								54.51	p.(=)		699	C=0.4549, T=0.5451		Present				-	9	NM_001014431.1	c.726G>A	synonymous	2.2				PH domain,Protein kinase C terminal domain,Protein kinase domain,Protein tyrosine kinase	rs1130233		0.314 (ref)	0.2459	0.1151	0.2016	YES	ATP binding,G-protein coupled receptor signaling pathway,RNA metabolic process,T cell costimulation,activation of pro-apoptotic gene products,activation-induced cell death of T cells,anti-apoptosis,apoptotic process,blood coagulation,carbohydrate metabolic process,carbohydrate transport,cell differentiation,cell proliferation,cellular response to insulin stimulus,cytoplasm,cytosol,endocrine pancreas development,enzyme binding,fibroblast growth factor receptor signaling pathway,identical protein binding,induction of apoptosis by intracellular signals,insulin receptor signaling pathway,insulin-like growth factor receptor signaling pathway,intracellular signal transduction,kinase activity,mRNA metabolic process,mammary gland epithelial cell differentiation,membrane fraction,microtubule cytoskeleton,multicellular organismal development,negative regulation of apoptotic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,negative regulation of fatty acid beta-oxidation,negative regulation of plasma membrane long-chain fatty acid transport,negative regulation of protein kinase activity,negative regulation of release of cytochrome c from mitochondria,nerve growth factor receptor signaling pathway,nervous system development,nitric oxide biosynthetic process,nitric oxide metabolic process,nitric-oxide synthase regulator activity,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,phosphatidylinositol-3,4,5-trisphosphate binding,phosphatidylinositol-3,4-bisphosphate binding,phosphatidylinositol-mediated signaling,phosphorylation,plasma membrane,platelet activation,positive regulation of anti-apoptosis,positive regulation of blood vessel endothelial cell migration,positive regulation of cell growth,positive regulation of cellular protein metabolic process,positive regulation of cyclin-dependent protein kinase activity involved in G1/S,positive regulation of establishment of protein localization in plasma membrane,positive regulation of fat cell differentiation,positive regulation of glucose import,positive regulation of glucose metabolic process,positive regulation of glycogen biosynthetic process,positive regulation of lipid biosynthetic process,positive regulation of nitric oxide biosynthetic process,positive regulation of nitric-oxide synthase activity,positive regulation of peptidyl-serine phosphorylation,positive regulation of protein phosphorylation,positive regulation of sequence-specific DNA binding transcription factor activity,protein autophosphorylation,protein binding,protein import into nucleus, translocation,protein kinase activity,protein modification process,protein phosphorylation,protein serine/threonine kinase activity,regulation of G1/S transition checkpoint,regulation of cell migration,regulation of glycogen biosynthetic process,regulation of neuron projection development,regulation of nitric-oxide synthase activity,regulation of translation,response to UV-A,response to fluid shear stress,response to heat,signal transduction,transport	5-(5-chloro-7H-pyrrolo2,3-dpyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo4,5-cpyridine,Adenosine triphosphate,Arsenic trioxide,Inositol 1,3,4,5-Tetrakisphosphate,N-2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl-7H-pyrrolo2,3-dpyrimidin-4-amine		0.00001	3749.52	C=318, T=381		C=158/160, T=197/184	1	
chr15:88576185	C/C	G	SNV		NTRK3	exonic	1								100.00	p.(=)		846	G=0.0, C=1.0		Present				-	14	NM_001012338.2	c.1488C>G	synonymous	-2.01				Immunoglobulin I-set domain,Immunoglobulin domain,Leucine rich repeat N-terminal domain,Protein kinase domain,Protein tyrosine kinase	rs2229910		0.322 (ref)	0.3551	0.4048	0.3719	YES	ATP binding,Golgi membrane,cell differentiation,cellular response to retinoic acid,cochlea development,cytoplasm,integral to plasma membrane,mechanoreceptor differentiation,membrane fraction,modulation by virus of host transcription,multicellular organismal development,negative regulation of astrocyte differentiation,negative regulation of cell death,nervous system development,neuron fate specification,neuron migration,neurotrophin binding,nucleotide binding,plasma membrane,positive regulation of axon extension involved in regeneration,protein autophosphorylation,receptor activity,response to axon injury,response to corticosterone stimulus,response to ethanol,response to stress,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway			0.00001	12596.6	G=0, C=846		G=0/0, C=366/480	2	
chr15:89838236	A/A	G	SNV		FANCI	exonic	1								100.00	p.(=)		1991	G=0.0, A=1.0		Present				+	24	NM_001113378.1	c.2547G>A	synonymous	0.3					rs7183618		0.027 (ref)	0.0535	0.0087	0.0399	YES	DNA repair,cell cycle,nucleoplasm,nucleus,plasma membrane,protein binding			0.00001	30028.7	G=0, A=1991		G=0/0, A=959/1032	2	
chr16:2134994	C/T	C	SNV		TSC2	exonic	1								66.64	p.(=)		1469	C=0.3336, T=0.6664		Present				+	35	NM_000548.3	c.4536C>T	synonymous	-0.45				Rap/ran-GAP,Tuberin	rs137854028,rs35986575			0.0055	0.0014	0.0041		14-3-3 protein binding,GTPase activator activity,Golgi apparatus,TSC1-TSC2 complex,acute-phase response,caveola,cell cycle arrest,cell projection organization,cytoplasm,cytoskeletal part,cytosol,dendrite,endocytosis,establishment of protein localization,fibroblast growth factor receptor signaling pathway,growth cone,heart development,insulin receptor signaling pathway,insulin-like growth factor receptor signaling pathway,intracellular,membrane,membrane fraction,microsome,negative regulation of MAP kinase activity,negative regulation of TOR signaling cascade,negative regulation of Wnt receptor signaling pathway,negative regulation of cell proliferation,negative regulation of cell size,negative regulation of epithelial cell proliferation,negative regulation of phosphatidylinositol 3-kinase cascade,negative regulation of protein kinase B signaling cascade,negative regulation of protein kinase activity,nerve growth factor receptor signaling pathway,neural tube closure,neuronal cell body,nucleus,perinuclear region of cytoplasm,phosphatase binding,phosphatidylinositol-mediated signaling,positive chemotaxis,positive regulation of GTPase activity,protein binding,protein heterodimerization activity,protein heterooligomerization,protein homodimerization activity,protein homooligomerization,protein import into nucleus,protein kinase B signaling cascade,protein localization,regulation of cell cycle,regulation of endocytosis,regulation of insulin receptor signaling pathway,regulation of small GTPase mediated signal transduction,response to hypoxia,signal transduction,vesicle-mediated transport		untested	0.00001	10949.5	C=490, T=979		C=256/234, T=479/500	1	
chr16:2138269	T/C	T	SNV		PKD1,TSC2	exonic, downstream	1								38.05	p.(=)		452	T=0.6195, C=0.3805		Present				+, -	41	NM_000548.3, NM_001009944.2	c.5202T>C	synonymous	0.34				Rap/ran-GAP,Tuberin	rs137854091,rs1748		0.258	0.1781	0.3656	0.3325	YES	14-3-3 protein binding,GTPase activator activity,Golgi apparatus,JAK-STAT cascade,TSC1-TSC2 complex,acute-phase response,anatomical structure morphogenesis,basolateral plasma membrane,blood vessel development,branching morphogenesis of a tube,calcium ion transport,calcium-independent cell-matrix adhesion,cartilage condensation,cation channel activity,caveola,cell cycle arrest,cell projection organization,cell-matrix adhesion,cilium,cytoplasm,cytoskeletal part,cytosol,dendrite,detection of mechanical stimulus,endocytosis,establishment of protein localization,fibroblast growth factor receptor signaling pathway,growth cone,heart development,homophilic cell adhesion,in utero embryonic development,insulin receptor signaling pathway,insulin-like growth factor receptor signaling pathway,integral to plasma membrane,intracellular,membrane,membrane fraction,microsome,motile primary cilium,negative regulation of MAP kinase activity,negative regulation of TOR signaling cascade,negative regulation of Wnt receptor signaling pathway,negative regulation of cell proliferation,negative regulation of cell size,negative regulation of epithelial cell proliferation,negative regulation of phosphatidylinositol 3-kinase cascade,negative regulation of protein kinase B signaling cascade,negative regulation of protein kinase activity,nerve growth factor receptor signaling pathway,neural tube closure,neuronal cell body,neuropeptide signaling pathway,nucleus,perinuclear region of cytoplasm,phosphatase binding,phosphatidylinositol-mediated signaling,plasma membrane,polycystin complex,positive chemotaxis,positive regulation of GTPase activity,protein binding,protein domain specific binding,protein heterodimerization activity,protein heterooligomerization,protein homodimerization activity,protein homooligomerization,protein import into nucleus,protein kinase B signaling cascade,protein kinase binding,protein localization,regulation of cell cycle,regulation of endocytosis,regulation of insulin receptor signaling pathway,regulation of small GTPase mediated signal transduction,response to hypoxia,signal transduction,sugar binding,vesicle-mediated transport		untested	0.00001	1352.67	T=280, C=172		T=136/144, C=81/91	1	
chr16:2138584	G/C	G	SNV		PKD1,TSC2	exonic, downstream	1								33.19	p.(=)		1371	G=0.6681, C=0.3319		Present				+, -	42	NM_000548.3, NM_001009944.2	c.5397G>C	synonymous	-5.34				Rap/ran-GAP,Tuberin	rs1051771		0.047 (ref)	0.0987	0.0187	0.0716	YES	14-3-3 protein binding,GTPase activator activity,Golgi apparatus,JAK-STAT cascade,TSC1-TSC2 complex,acute-phase response,anatomical structure morphogenesis,basolateral plasma membrane,blood vessel development,branching morphogenesis of a tube,calcium ion transport,calcium-independent cell-matrix adhesion,cartilage condensation,cation channel activity,caveola,cell cycle arrest,cell projection organization,cell-matrix adhesion,cilium,cytoplasm,cytoskeletal part,cytosol,dendrite,detection of mechanical stimulus,endocytosis,establishment of protein localization,fibroblast growth factor receptor signaling pathway,growth cone,heart development,homophilic cell adhesion,in utero embryonic development,insulin receptor signaling pathway,insulin-like growth factor receptor signaling pathway,integral to plasma membrane,intracellular,membrane,membrane fraction,microsome,motile primary cilium,negative regulation of MAP kinase activity,negative regulation of TOR signaling cascade,negative regulation of Wnt receptor signaling pathway,negative regulation of cell proliferation,negative regulation of cell size,negative regulation of epithelial cell proliferation,negative regulation of phosphatidylinositol 3-kinase cascade,negative regulation of protein kinase B signaling cascade,negative regulation of protein kinase activity,nerve growth factor receptor signaling pathway,neural tube closure,neuronal cell body,neuropeptide signaling pathway,nucleus,perinuclear region of cytoplasm,phosphatase binding,phosphatidylinositol-mediated signaling,plasma membrane,polycystin complex,positive chemotaxis,positive regulation of GTPase activity,protein binding,protein domain specific binding,protein heterodimerization activity,protein heterooligomerization,protein homodimerization activity,protein homooligomerization,protein import into nucleus,protein kinase B signaling cascade,protein kinase binding,protein localization,regulation of cell cycle,regulation of endocytosis,regulation of insulin receptor signaling pathway,regulation of small GTPase mediated signal transduction,response to hypoxia,signal transduction,sugar binding,vesicle-mediated transport		untested	0.00001	3284.88	G=916, C=455		G=466/450, C=227/228	2	
chr16:3639139	A/G	A	SNV		SLX4	exonic	1								32.03	p.(=)		765	A=0.6797, G=0.3203		Present				-	12	NM_032444.2	c.4500T>C	synonymous	0.83				BTB/POZ domain	rs3810812		0.306 (ref)	0.4923	0.1406	0.3734	YES	3'-flap endonuclease activity,5'-flap endonuclease activity,DNA double-strand break processing involved in repair via single-strand annealing,DNA recombination,DNA repair,ERCC4-ERCC1 complex,Holliday junction resolvase complex,Slx1-Slx4 complex,crossover junction endodeoxyribonuclease activity,double-strand break repair via homologous recombination,enzyme activator activity,nuclear chromatin,nuclear chromosome, telomeric region,nucleotide-excision repair,nucleus,positive regulation of catalytic activity,protein binding			0.00001	1723.86	A=520, G=245		A=246/274, G=143/102	1	
chr16:3639782	G/A	G	SNV		SLX4	exonic	1								66.73	p.Ala1286Val		1536	G=0.3327, A=0.6673		Present				-	12	NM_032444.2	c.3857C>T	missense	-0.44	0.09	64.0	0.0	BTB/POZ domain	rs149011965		0.004 (ref)	0.0031	5.0E-4	0.0022		3'-flap endonuclease activity,5'-flap endonuclease activity,DNA double-strand break processing involved in repair via single-strand annealing,DNA recombination,DNA repair,ERCC4-ERCC1 complex,Holliday junction resolvase complex,Slx1-Slx4 complex,crossover junction endodeoxyribonuclease activity,double-strand break repair via homologous recombination,enzyme activator activity,nuclear chromatin,nuclear chromosome, telomeric region,nucleotide-excision repair,nucleus,positive regulation of catalytic activity,protein binding			0.00001	11447.1	G=511, A=1025		G=263/248, A=589/436	1	
chr16:3656482	C/T	C	SNV		SLX4	exonic	1								33.69	p.(=)		1300	C=0.6631, T=0.3369		Present				-	3	NM_032444.2	c.753G>A	synonymous	-3.47				BTB/POZ domain	rs8061528		0.25 (ref)	0.203	0.2501	0.2189	YES	3'-flap endonuclease activity,5'-flap endonuclease activity,DNA double-strand break processing involved in repair via single-strand annealing,DNA recombination,DNA repair,ERCC4-ERCC1 complex,Holliday junction resolvase complex,Slx1-Slx4 complex,crossover junction endodeoxyribonuclease activity,double-strand break repair via homologous recombination,enzyme activator activity,nuclear chromatin,nuclear chromosome, telomeric region,nucleotide-excision repair,nucleus,positive regulation of catalytic activity,protein binding			0.00001	3197.94	C=862, T=438		C=435/427, T=201/237	4	
chr16:89838086	C/A	C	SNV		FANCA	exonic	1								49.30	p.Met717Ile		935	C=0.507, A=0.493		Present				-	23	NM_000135.2	c.2151G>T	missense	2.21	0.19	10.0	0.002	Fanconi anaemia group A protein	rs1131660		0.026 (ref)	0.0309	0.0055	0.0223	YES	DNA repair,Fanconi anaemia nuclear complex,cytoplasm,female gonad development,male gonad development,male meiosis,nucleoplasm,nucleus,protein binding,protein complex assembly,regulation of cell proliferation			0.00001	4272.7	C=474, A=461		C=190/284, A=185/276	2	
chr16:89849480	C/T	C	SNV		FANCA	exonic	1								50.29	p.Gly501Ser		1565	C=0.4971, T=0.5029		Present				-	16	NM_000135.2	c.1501G>A	missense	-1.69	1.0	56.0	0.0	Fanconi anaemia group A protein	rs2239359		0.393 (ref)	0.381	0.3196	0.4823	YES	DNA repair,Fanconi anaemia nuclear complex,cytoplasm,female gonad development,male gonad development,male meiosis,nucleoplasm,nucleus,protein binding,protein complex assembly,regulation of cell proliferation			0.00001	7384.27	C=778, T=787		C=362/416, T=315/472	2	
chr17:7577549	GC/G	GC	INDEL		TP53	exonic	1	Deleterious	Loss-of-function						39.02	p.Gly244fs		1994	GC=0.6098, G=0.3902		Present				-	7	NM_000546.5	c.731delG	frameshiftDeletion	-2.59,2.56				P53 DNA-binding domain,P53 tetramerisation motif,P53 transactivation motif								ATP binding,B cell lineage commitment,DNA binding,DNA damage response, signal transduction by p53 class mediator,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA strand annealing activity,DNA strand renaturation,ER overload response,MDM2 binding,PML body,RNA polymerase II transcription factor binding,Ras protein signal transduction,T cell differentiation in thymus,T cell lineage commitment,T cell proliferation involved in immune response,activation of caspase activity by cytochrome c,apoptotic process,base-excision repair,blood coagulation,cell aging,cell cycle arrest,cell cycle checkpoint,cell differentiation,cell proliferation,cellular protein localization,cellular response to UV,cellular response to drug,cellular response to glucose starvation,cellular response to hypoxia,cellular response to ionizing radiation,central nervous system development,chaperone binding,chromatin,chromatin assembly complex,chromatin binding,chromosome organization,copper ion binding,cytoplasm,cytosol,damaged DNA binding,determination of adult lifespan,double-strand break repair,embryo development ending in birth or egg hatching,endoplasmic reticulum,enzyme binding,gastrulation,histone acetyltransferase binding,histone deacetylase regulator activity,identical protein binding,in utero embryonic development,induction of apoptosis by intracellular signals,insoluble fraction,interspecies interaction between organisms,metal ion binding,mitochondrion,mitotic cell cycle G1/S transition DNA damage checkpoint,multicellular organism growth,multicellular organismal development,negative regulation of DNA replication,negative regulation of apoptotic process,negative regulation of cell growth,negative regulation of cell proliferation,negative regulation of fibroblast proliferation,negative regulation of helicase activity,negative regulation of neuroblast proliferation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,negative regulation of transforming growth factor beta receptor signaling pathway,nuclear body,nuclear chromatin,nuclear matrix,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,oxidative stress-induced premature senescence,p53 binding,positive regulation of apoptotic process,positive regulation of cell aging,positive regulation of cell cycle arrest,positive regulation of histone deacetylation,positive regulation of neuron apoptosis,positive regulation of peptidyl-tyrosine phosphorylation,positive regulation of reactive oxygen species metabolic process,positive regulation of thymocyte apoptosis,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,protease binding,protein N-terminus binding,protein binding,protein complex,protein complex assembly,protein heterodimerization activity,protein import into nucleus, translocation,protein kinase binding,protein localization,protein phosphatase 2A binding,protein tetramerization,rRNA transcription,regulation of apoptotic process,regulation of cell cycle,regulation of mitochondrial membrane permeability,regulation of transcription, DNA-dependent,release of cytochrome c from mitochondria,replication fork,replicative senescence,response to DNA damage stimulus,response to X-ray,response to antibiotic,response to gamma radiation,sequence-specific DNA binding transcription factor activity,signal transduction by p53 class mediator resulting in induction of apoptosis,somitogenesis,transcription factor TFIID complex,transcription factor binding,transcription regulatory region DNA binding,ubiquitin protein ligase binding,zinc ion binding	1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine		0.00001	6082.58	GC=1216, G=778		GC=560/656, G=351/427	3	
chr17:7578210	T/C	T	SNV		TP53	exonic	1								29.94	p.(=)		1269	T=0.7006, C=0.2994		Present				-	6	NM_000546.5	c.639A>G	synonymous	-0.16				P53 DNA-binding domain,P53 tetramerisation motif,P53 transactivation motif	rs1800372		0.007	0.0193	0.0027	0.0137	YES	ATP binding,B cell lineage commitment,DNA binding,DNA damage response, signal transduction by p53 class mediator,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA strand annealing activity,DNA strand renaturation,ER overload response,MDM2 binding,PML body,RNA polymerase II transcription factor binding,Ras protein signal transduction,T cell differentiation in thymus,T cell lineage commitment,T cell proliferation involved in immune response,activation of caspase activity by cytochrome c,apoptotic process,base-excision repair,blood coagulation,cell aging,cell cycle arrest,cell cycle checkpoint,cell differentiation,cell proliferation,cellular protein localization,cellular response to UV,cellular response to drug,cellular response to glucose starvation,cellular response to hypoxia,cellular response to ionizing radiation,central nervous system development,chaperone binding,chromatin,chromatin assembly complex,chromatin binding,chromosome organization,copper ion binding,cytoplasm,cytosol,damaged DNA binding,determination of adult lifespan,double-strand break repair,embryo development ending in birth or egg hatching,endoplasmic reticulum,enzyme binding,gastrulation,histone acetyltransferase binding,histone deacetylase regulator activity,identical protein binding,in utero embryonic development,induction of apoptosis by intracellular signals,insoluble fraction,interspecies interaction between organisms,metal ion binding,mitochondrion,mitotic cell cycle G1/S transition DNA damage checkpoint,multicellular organism growth,multicellular organismal development,negative regulation of DNA replication,negative regulation of apoptotic process,negative regulation of cell growth,negative regulation of cell proliferation,negative regulation of fibroblast proliferation,negative regulation of helicase activity,negative regulation of neuroblast proliferation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,negative regulation of transforming growth factor beta receptor signaling pathway,nuclear body,nuclear chromatin,nuclear matrix,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,oxidative stress-induced premature senescence,p53 binding,positive regulation of apoptotic process,positive regulation of cell aging,positive regulation of cell cycle arrest,positive regulation of histone deacetylation,positive regulation of neuron apoptosis,positive regulation of peptidyl-tyrosine phosphorylation,positive regulation of reactive oxygen species metabolic process,positive regulation of thymocyte apoptosis,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,protease binding,protein N-terminus binding,protein binding,protein complex,protein complex assembly,protein heterodimerization activity,protein import into nucleus, translocation,protein kinase binding,protein localization,protein phosphatase 2A binding,protein tetramerization,rRNA transcription,regulation of apoptotic process,regulation of cell cycle,regulation of mitochondrial membrane permeability,regulation of transcription, DNA-dependent,release of cytochrome c from mitochondria,replication fork,replicative senescence,response to DNA damage stimulus,response to X-ray,response to antibiotic,response to gamma radiation,sequence-specific DNA binding transcription factor activity,signal transduction by p53 class mediator resulting in induction of apoptosis,somitogenesis,transcription factor TFIID complex,transcription factor binding,transcription regulatory region DNA binding,ubiquitin protein ligase binding,zinc ion binding	1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine		0.00001	2568.19	T=889, C=380		T=456/433, C=209/171	1	
chr17:7579472	G/C	G	SNV		TP53	exonic	1								95.63	p.Pro72Arg		1556	G=0.0437, C=0.9563		Present				-	4	NM_000546.5	c.215C>G	missense	1.36	0.6	103.0	0.083	P53 DNA-binding domain,P53 tetramerisation motif,P53 transactivation motif	rs1042522		0.398 (ref)	0.2548	0.4051	0.37	YES	ATP binding,B cell lineage commitment,DNA binding,DNA damage response, signal transduction by p53 class mediator,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA strand annealing activity,DNA strand renaturation,ER overload response,MDM2 binding,PML body,RNA polymerase II transcription factor binding,Ras protein signal transduction,T cell differentiation in thymus,T cell lineage commitment,T cell proliferation involved in immune response,activation of caspase activity by cytochrome c,apoptotic process,base-excision repair,blood coagulation,cell aging,cell cycle arrest,cell cycle checkpoint,cell differentiation,cell proliferation,cellular protein localization,cellular response to UV,cellular response to drug,cellular response to glucose starvation,cellular response to hypoxia,cellular response to ionizing radiation,central nervous system development,chaperone binding,chromatin,chromatin assembly complex,chromatin binding,chromosome organization,copper ion binding,cytoplasm,cytosol,damaged DNA binding,determination of adult lifespan,double-strand break repair,embryo development ending in birth or egg hatching,endoplasmic reticulum,enzyme binding,gastrulation,histone acetyltransferase binding,histone deacetylase regulator activity,identical protein binding,in utero embryonic development,induction of apoptosis by intracellular signals,insoluble fraction,interspecies interaction between organisms,metal ion binding,mitochondrion,mitotic cell cycle G1/S transition DNA damage checkpoint,multicellular organism growth,multicellular organismal development,negative regulation of DNA replication,negative regulation of apoptotic process,negative regulation of cell growth,negative regulation of cell proliferation,negative regulation of fibroblast proliferation,negative regulation of helicase activity,negative regulation of neuroblast proliferation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,negative regulation of transforming growth factor beta receptor signaling pathway,nuclear body,nuclear chromatin,nuclear matrix,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,oxidative stress-induced premature senescence,p53 binding,positive regulation of apoptotic process,positive regulation of cell aging,positive regulation of cell cycle arrest,positive regulation of histone deacetylation,positive regulation of neuron apoptosis,positive regulation of peptidyl-tyrosine phosphorylation,positive regulation of reactive oxygen species metabolic process,positive regulation of thymocyte apoptosis,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,protease binding,protein N-terminus binding,protein binding,protein complex,protein complex assembly,protein heterodimerization activity,protein import into nucleus, translocation,protein kinase binding,protein localization,protein phosphatase 2A binding,protein tetramerization,rRNA transcription,regulation of apoptotic process,regulation of cell cycle,regulation of mitochondrial membrane permeability,regulation of transcription, DNA-dependent,release of cytochrome c from mitochondria,replication fork,replicative senescence,response to DNA damage stimulus,response to X-ray,response to antibiotic,response to gamma radiation,sequence-specific DNA binding transcription factor activity,signal transduction by p53 class mediator resulting in induction of apoptosis,somitogenesis,transcription factor TFIID complex,transcription factor binding,transcription regulatory region DNA binding,ubiquitin protein ligase binding,zinc ion binding	1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine	non-pathogenic	0.00001	21528.3	G=68, C=1488		G=13/55, C=555/933	6	
chr17:29508775	A/A	G	SNV		NF1	exonic	1								100.00	p.(=)		1993	G=0.0, A=1.0		Present				+	7	NM_001042492.2	c.702G>A	synonymous	-3.81				GTPase-activator protein for Ras-like GTPase	rs1801052		0.45 (ref)	0.2899	0.3098	0.4256	YES	MAPKKK cascade,Ras GTPase activator activity,Ras protein signal transduction,Schwann cell development,actin cytoskeleton organization,adrenal gland development,artery morphogenesis,axon,brain development,camera-type eye morphogenesis,cell communication,cerebral cortex development,cognition,collagen fibril organization,cytoplasm,dendrite,extracellular matrix organization,forebrain astrocyte development,forebrain morphogenesis,heart development,intracellular,intrinsic to internal side of plasma membrane,liver development,metanephros development,myelination in peripheral nervous system,negative regulation of MAP kinase activity,negative regulation of MAPKKK cascade,negative regulation of Rac protein signal transduction,negative regulation of Ras protein signal transduction,negative regulation of angiogenesis,negative regulation of astrocyte differentiation,negative regulation of cell migration,negative regulation of endothelial cell proliferation,negative regulation of fibroblast proliferation,negative regulation of neuroblast proliferation,negative regulation of neurotransmitter secretion,negative regulation of oligodendrocyte differentiation,negative regulation of protein kinase activity,negative regulation of transcription factor import into nucleus,neural tube development,nucleus,osteoblast differentiation,peripheral nervous system development,phosphatidylinositol 3-kinase cascade,pigmentation,positive regulation of Ras GTPase activity,positive regulation of adenylate cyclase activity,positive regulation of apoptotic process,positive regulation of endothelial cell proliferation,positive regulation of neuron apoptosis,protein binding,regulation of Ras GTPase activity,regulation of angiogenesis,regulation of blood vessel endothelial cell migration,regulation of bone resorption,regulation of cell-matrix adhesion,regulation of glial cell differentiation,regulation of long-term neuronal synaptic plasticity,regulation of small GTPase mediated signal transduction,regulation of synaptic transmission, GABAergic,response to hypoxia,signal transduction,skeletal muscle tissue development,smooth muscle tissue development,spinal cord development,sympathetic nervous system development,visual learning,wound healing			0.00001	30311.6	G=0, A=1993		G=0/0, A=1268/725	1	
chr17:29652923	A/G	A	SNV		NF1	exonic	1								40.16	p.Ile1641Val		1793	A=0.5984, G=0.4016		Present				+	37	NM_001042492.2	c.4921A>G	missense	2.13	0.51	29.0	0.0	GTPase-activator protein for Ras-like GTPase								MAPKKK cascade,Ras GTPase activator activity,Ras protein signal transduction,Schwann cell development,actin cytoskeleton organization,adrenal gland development,artery morphogenesis,axon,brain development,camera-type eye morphogenesis,cell communication,cerebral cortex development,cognition,collagen fibril organization,cytoplasm,dendrite,extracellular matrix organization,forebrain astrocyte development,forebrain morphogenesis,heart development,intracellular,intrinsic to internal side of plasma membrane,liver development,metanephros development,myelination in peripheral nervous system,negative regulation of MAP kinase activity,negative regulation of MAPKKK cascade,negative regulation of Rac protein signal transduction,negative regulation of Ras protein signal transduction,negative regulation of angiogenesis,negative regulation of astrocyte differentiation,negative regulation of cell migration,negative regulation of endothelial cell proliferation,negative regulation of fibroblast proliferation,negative regulation of neuroblast proliferation,negative regulation of neurotransmitter secretion,negative regulation of oligodendrocyte differentiation,negative regulation of protein kinase activity,negative regulation of transcription factor import into nucleus,neural tube development,nucleus,osteoblast differentiation,peripheral nervous system development,phosphatidylinositol 3-kinase cascade,pigmentation,positive regulation of Ras GTPase activity,positive regulation of adenylate cyclase activity,positive regulation of apoptotic process,positive regulation of endothelial cell proliferation,positive regulation of neuron apoptosis,protein binding,regulation of Ras GTPase activity,regulation of angiogenesis,regulation of blood vessel endothelial cell migration,regulation of bone resorption,regulation of cell-matrix adhesion,regulation of glial cell differentiation,regulation of long-term neuronal synaptic plasticity,regulation of small GTPase mediated signal transduction,regulation of synaptic transmission, GABAergic,response to hypoxia,signal transduction,skeletal muscle tissue development,smooth muscle tissue development,spinal cord development,sympathetic nervous system development,visual learning,wound healing			0.00001	5900.41	A=1073, G=720		A=605/468, G=373/347	3	
chr17:33433487	T/T	C	SNV		RAD51D,RAD51L3-RFFL	exonic_nc, exonic, exonic, exonic, exonic_nc, exonic_nc	1								100.00	p.Arg53Gln, p.Arg185Gln, p.Arg165Gln		1986	C=0.0, T=1.0		Present				-	6	NR_037714.1, NM_133629.2, NM_001142571.1, NM_002878.3, NR_037712.1, NR_037711.1	c.158G>A, c.554G>A, c.494G>A	missense, missense, missense	-0.16		43.0, 43.0, 43.0			rs4796033		0.097 (ref)	0.1427	0.0368	0.1068	YES	ATP binding,DNA binding,DNA metabolic process,DNA recombination,DNA repair,DNA-dependent ATPase activity,nucleoside-triphosphatase activity,nucleotide binding,nucleus,reciprocal meiotic recombination			0.00001	30061.6	C=0, T=1986		C=0/0, T=961/1025	2	
chr17:33445549	G/A	G	SNV		RAD51D,RAD51L3-RFFL	intronic_nc, intronic, intronic, exonic, intronic_nc, intronic_nc	1								45.32	p.(=)		1999	G=0.5468, A=0.4532		Present				-	3	NR_037714.1, NM_133629.2, NM_001142571.1, NM_002878.3, NR_037712.1, NR_037711.1	c.234C>T	synonymous	1.21					rs9901455		0.191 (ref)	0.082	0.308	0.1585	YES	ATP binding,DNA binding,DNA metabolic process,DNA recombination,DNA repair,DNA-dependent ATPase activity,nucleoside-triphosphatase activity,nucleotide binding,nucleus,reciprocal meiotic recombination			0.00001	8017.56	G=1093, A=906		G=558/535, A=470/436	2	
chr17:37879588	A/G	A	SNV		ERBB2	exonic	1								48.59	p.Ile655Val		1628	A=0.5141, G=0.4859		Present				+	17	NM_004448.3	c.1963A>G	missense	1.88	1.0	29.0	0.406	Furin-like cysteine rich region,Protein kinase domain,Protein tyrosine kinase,Receptor L domain	rs1136201		0.156	0.2302	0.0481	0.1685	YES	ATP binding,ErbB-3 class receptor binding,Hsp90 protein binding,RNA polymerase I core binding,apical plasma membrane,axon guidance,basal plasma membrane,basolateral plasma membrane,cell proliferation,cell surface receptor linked signaling pathway,cytoplasm,endosome membrane,enzyme linked receptor protein signaling pathway,epidermal growth factor receptor signaling pathway,epidermal growth factor-activated receptor activity,estrus,glial cell differentiation,glycoprotein binding,growth factor binding,heart development,identical protein binding,integral to membrane,lateral loop,liver development,mammary gland development,mammary gland involution,membrane raft,microvillus,motor axon guidance,myelination,negative regulation of apoptotic process,negative regulation of immature T cell proliferation in thymus,nervous system development,neuromuscular junction development,nucleotide binding,nucleus,perinuclear region of cytoplasm,peripheral nervous system development,phosphatidylinositol 3-kinase cascade,phosphatidylinositol-mediated signaling,plasma membrane,positive regulation of MAP kinase activity,positive regulation of MAPKKK cascade,positive regulation of Ras protein signal transduction,positive regulation of cell adhesion,positive regulation of cell growth,positive regulation of epithelial cell proliferation,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of transcription from RNA polymerase I promoter,positive regulation of transcription from RNA polymerase III promoter,positive regulation of translation,postsynaptic membrane,protein C-terminus binding,protein autophosphorylation,protein binding,protein dimerization activity,protein heterodimerization activity,protein phosphatase binding,protein phosphorylation,protein tyrosine kinase activity,receptor activity,receptor complex,receptor signaling protein tyrosine kinase activity,regulation of ERK1 and ERK2 cascade,regulation of angiogenesis,regulation of microtubule-based process,regulation of transcription, DNA-dependent,response to axon injury,response to drug,response to progesterone stimulus,signal transduction,skeletal muscle tissue development,sympathetic nervous system development,tongue development,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway,transmembrane signaling receptor activity,ubiquitin protein ligase binding,wound healing	Lapatinib,Trastuzumab	non-pathogenic	0.00001	7292.04	A=837, G=791		A=444/393, G=415/376	1	
chr17:41223094	C/C	T	SNV		BRCA1	exonic	1								100.00	p.Ser1634Gly		1991	T=0.0, C=1.0		Present				-	16	NM_007300.3	c.4900A>G	missense	0.13	0.03	56.0	0.58	BRCA1 C Terminus (BRCT) domain,Zinc finger	rs1799966		0.327	0.3266	0.2426	0.2982	YES	BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding		non-pathogenic	0.00001	30138.9	T=0, C=1991		T=0/0, C=937/1054	1	
chr17:41226462		T	GENE_EXPRESSION		BRCA1								BRCA1-BRCA1.B13B15.V14es				65				Present			2.8596e-11																						0.0					
chr17:41226462		T	GENE_EXPRESSION		BRCA1								BRCA1-BRCA1.B4B15.V5es				163				Present			7.1709e-11																						0.0					
chr17:41234470	G/G	A	SNV		BRCA1	exonic	1								100.00	p.(=)		1991	A=0.0, G=1.0		Present				-	12	NM_007300.3	c.4308T>C	synonymous	0.13				BRCA1 C Terminus (BRCT) domain,Zinc finger	rs1060915		0.304 (ref)	0.326	0.1888	0.2796	YES	BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding		untested	0.00001	30202.2	A=0, G=1991		A=0/0, G=958/1033	2	
chr17:41244000	C/C	T	SNV		BRCA1	exonic	1								100.00	p.Lys1183Arg		1987	T=0.0, C=1.0		Present				-	10	NM_007300.3	c.3548A>G	missense	-0.44	1.0	26.0	0.0	BRCA1 C Terminus (BRCT) domain,Zinc finger	rs16942,rs80357956		0.324 (ref)	0.3244	0.2383	0.2952	YES	BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding		non-pathogenic	0.00001	30033.1	T=0, C=1987		T=0/0, C=1024/963	3	
chr17:41244435	C/C	T	SNV		BRCA1	exonic	1								100.00	p.Glu1038Gly		1995	T=0.0, C=1.0		Present				-	10	NM_007300.3	c.3113A>G	missense	0.11	0.02	98.0	0.158	BRCA1 C Terminus (BRCT) domain,Zinc finger	rs16941,rs80357920		0.303 (ref)	0.3255	0.1884	0.279	YES	BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding		non-pathogenic	0.00001	30307.0	T=0, C=1995		T=0/0, C=1035/960	2	
chr17:41244936	A/A	G	SNV		BRCA1	exonic	1								100.00	p.Pro871Leu		1987	G=0.0, A=1.0		Present				-	10	NM_007300.3	c.2612C>T	missense	0.94	1.0	98.0	0.0	BRCA1 C Terminus (BRCT) domain,Zinc finger	rs799917,rs80357962		0.483	0.3359	0.2	0.4932	YES	BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding		non-pathogenic	0.00001	30054.2	G=0, A=1987		G=0/0, A=988/999	2	
chr17:41245237	G/G	A	SNV		BRCA1	exonic	1								100.00	p.(=)		1994	A=0.0, G=1.0		Present				-	10	NM_007300.3	c.2311T>C	synonymous	-0.83				BRCA1 C Terminus (BRCT) domain,Zinc finger	rs16940		0.302 (ref)	0.3237	0.1877	0.2776	YES	BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding		untested	0.00001	30270.4	A=0, G=1994		A=0/0, G=984/1010	2	
chr17:41245466	A/A	G	SNV		BRCA1	exonic	1								100.00	p.(=)		1987	G=0.0, A=1.0		Present				-	10	NM_007300.3	c.2082C>T	synonymous	-0.08				BRCA1 C Terminus (BRCT) domain,Zinc finger	rs1799949		0.324 (ref)	0.3244	0.2396	0.2957	YES	BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding		untested	0.00001	30029.0	G=0, A=1987		G=0/0, A=987/1000	1	
chr17:41245471	C/T	C	SNV		BRCA1	exonic	1								57.56	p.Asp693Asn		1998	C=0.4244, T=0.5756		Present				-	10	NM_007300.3	c.2077G>A	missense	0.13	0.05	23.0	0.001	BRCA1 C Terminus (BRCT) domain,Zinc finger	rs4986850		0.039	0.0702	0.0232	0.0543	YES	BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding		non-pathogenic	0.00001	11761.3	C=848, T=1150		C=405/443, T=609/541	1	
chr17:56435080	G/C	G	SNV		RNF43	exonic	1								25.92	p.Pro686Arg		1964	G=0.7408, C=0.2592		Present				-	9	NM_017763.4	c.2057C>G	missense	0.7	0.0	103.0	0.001	Zinc finger	rs9652855		0.08 (ref)	0.1258	0.1182	0.1233	YES	endoplasmic reticulum,endoplasmic reticulum membrane,integral to membrane,ligase activity,membrane,metal ion binding,nuclear envelope,nucleus,protein binding,zinc ion binding			0.00001	3090.98	G=1455, C=509		G=777/678, C=268/241	5	
chr17:56435885	G/T	G	SNV		RNF43	exonic	1								72.74	p.Leu418Met		1992	G=0.2726, T=0.7274		Present				-	9	NM_017763.4	c.1252C>A	missense	2.18	0.0	15.0	0.948	Zinc finger	rs2526374		0.398 (ref)	0.3591	0.4024	0.3738	YES	endoplasmic reticulum,endoplasmic reticulum membrane,integral to membrane,ligase activity,membrane,metal ion binding,nuclear envelope,nucleus,protein binding,zinc ion binding			0.00001	17123.0	G=543, T=1449		G=260/283, T=665/784	1	
chr17:56492800	T/C	T	SNV		RNF43	exonic	1								75.53	p.Ile47Val		1998	T=0.2447, C=0.7553		Present				-	2	NM_017763.4	c.139A>G	missense	0.97	0.1	29.0	0.001	Zinc finger	rs3744093		0.392 (ref)	0.3851	0.2174	0.3283	YES	endoplasmic reticulum,endoplasmic reticulum membrane,integral to membrane,ligase activity,membrane,metal ion binding,nuclear envelope,nucleus,protein binding,zinc ion binding			0.00001	18295.0	T=489, C=1509		T=201/288, C=737/772	1	
chr19:11105608	C/C	T	SNV		SMARCA4	exonic	1								100.00	p.(=)		1986	T=0.0, C=1.0		Present				+	9	NM_001128849.1	c.1524T>C	synonymous	-1.57				BRK domain,Bromodomain,HSA,Helicase conserved C-terminal domain,SNF2 family N-terminal domain	rs7935		0.312 (ref)	0.3409	0.3037	0.3283	YES	ATP binding,DNA binding,DNA methylation on cytosine within a CG sequence,SWI/SNF complex,blastocyst growth,blastocyst hatching,cell morphogenesis,chromatin binding,chromatin remodeling,definitive erythrocyte differentiation,embryonic hindlimb morphogenesis,embryonic organ morphogenesis,epidermis morphogenesis,extracellular matrix organization,forebrain development,glial cell fate determination,heart development,heart trabecula formation,helicase activity,heterochromatin,hindbrain development,histone H3 acetylation,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,in utero embryonic development,keratinocyte differentiation,liver development,methylation-dependent chromatin silencing,nBAF complex,negative regulation of transcription from RNA polymerase II promoter,nervous system development,npBAF complex,nuclear euchromatin,nucleus,perichromatin fibrils,positive regulation of transcription from RNA polymerase II promoter,regulation of transcription, DNA-dependent,soluble fraction,transcription factor binding,vasculogenesis			0.00001	30047.8	T=0, C=1986		T=0/0, C=1109/877	1	
chr19:15271771	G/A	G	SNV		NOTCH3	exonic	1								69.51	p.Ala2223Val		1561	G=0.3049, A=0.6951		Present				-	33	NM_000435.2	c.6668C>T	missense	0.08	0.18	64.0	0.001	Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein	rs1044009		0.368 (ref)	0.1987	0.397	0.2651	YES	Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration			0.00001	12410.7	G=476, A=1085		G=242/234, A=572/513	1	
chr19:15278057	A/G	A	SNV		NOTCH3	splicesite_3	1								68.47			1649	A=0.3153, G=0.6847		Present				-	29	NM_000435.2			0.62				Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein	rs1548555		0.133 (ref)	0.1034	0.0236	0.0763	YES	Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration			0.00001	12802.2	A=520, G=1129		A=221/299, G=504/625	2	
chr19:15285052	T/C	T	SNV		NOTCH3	exonic	1								66.70	p.(=)		1021	T=0.333, C=0.667		Present				-	25	NM_000435.2	c.4563A>G	synonymous	-1.43				Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein	rs1044006		0.133 (ref)	0.1002	0.0223	0.0739	YES	Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration			0.00001	7580.64	T=340, C=681		T=143/197, C=297/384	1	
chr19:15290953	T/G	T	SNV		MIR6795,NOTCH3	exonic, upstream	1								4.72	p.Asp1086Ala		1993	T=0.9528, G=0.0472		Present				-	20	NM_000435.2, NR_106853.1	c.3257A>C	missense	1.82	0.0	126.0	0.993	Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein								Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration			0.00001	48.962	T=1899, G=94		T=905/994, G=30/64	1	
chr19:15292437	T/C	T	SNV		NOTCH3	exonic	1								66.96	p.(=)		560	T=0.3304, C=0.6696		Present				-	17	NM_000435.2	c.2742A>G	synonymous	-4.38				Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein	rs1043997		0.233 (ref)	0.1299	0.3636	0.2095	YES	Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration			0.00001	4151.34	T=185, C=375		T=101/84, C=191/184	1	
chr19:15295134	G/A	G	SNV		NOTCH3	exonic	1								68.72	p.(=)		911	G=0.3128, A=0.6872		Present				-	16	NM_000435.2	c.2538C>T	synonymous	-0.59				Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein	rs1043996		0.462 (ref)	0.2849	0.2762	0.4336	YES	Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration			0.00001	7135.85	G=285, A=626		G=145/140, A=297/329	1	
chr19:15299051	G/A	G	SNV		NOTCH3	exonic	1								66.23	p.Pro496Leu		1999	G=0.3377, A=0.6623		Present				-	9	NM_000435.2	c.1487C>T	missense	2.35	0.03	98.0	0.987	Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein	rs11670799		0.006 (ref)	0.0215	0.0039	0.0155	YES	Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration			0.00001	14772.2	G=675, A=1324		G=331/344, A=733/591	4	
chr19:15300136	A/G	A	SNV		NOTCH3	exonic	1								67.84	p.(=)		1993	A=0.3216, G=0.6784		Present				-	7	NM_000435.2	c.1140T>C	synonymous	-1.4				Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein	rs61749020		0.014	0.038	0.0188	0.0315	YES	Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration			0.00001	15131.3	A=641, G=1352		A=316/325, G=665/687	1	
chr19:15302844	T/C	T	SNV		NOTCH3	exonic	1								64.28	p.(=)		1999	T=0.3572, C=0.6428		Present				-	4	NM_000435.2	c.606A>G	synonymous	-2.59				Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein	rs1043994		0.144 (ref)	0.1224	0.0878	0.1107	YES	Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration			0.00001	14072.0	T=714, C=1285		T=349/365, C=585/700	1	
chr19:40762915	G/A	G	SNV		AKT2	exonic	1								71.52	p.(=)		1998	G=0.2848, A=0.7152		Present				-	3	NM_001626.5	c.93C>T	synonymous	-0.33				PH domain,Protein kinase C terminal domain,Protein kinase domain,Protein tyrosine kinase	rs35588791		0.003 (ref)	0.0036	0.0014	0.0028		ATP binding,carbohydrate metabolic process,carbohydrate transport,cellular response to chemical stimulus,cellular response to hormone stimulus,cellular response to insulin stimulus,cytoplasm,cytosol,fat cell differentiation,insulin receptor signaling pathway,insulin-responsive compartment,kinase activity,lamellipodium,mammary gland epithelial cell differentiation,microsome,mitochondrion,multicellular organismal development,negative regulation of RNA splicing,negative regulation of apoptotic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,negative regulation of plasma membrane long-chain fatty acid transport,nucleoplasm,nucleotide binding,nucleus,phosphorylation,plasma membrane,positive regulation of cell migration,positive regulation of cell motility,positive regulation of fatty acid beta-oxidation,positive regulation of gene expression,positive regulation of glucose import,positive regulation of glucose metabolic process,positive regulation of glycogen biosynthetic process,positive regulation of nitric oxide biosynthetic process,positive regulation of peptidyl-serine phosphorylation,positive regulation of positive chemotaxis,positive regulation of signal transduction,positive regulation of sodium ion transport,positive regulation of transcription from RNA polymerase II promoter,protein binding,protein kinase B signaling cascade,protein kinase C binding,protein modification process,protein serine/threonine kinase activity,regulation of JNK cascade,regulation of cell cycle arrest,regulation of cell migration,regulation of translation,response to muscle activity,response to osmotic stress,signal transduction,soluble fraction,transport,vesicle	(2S)-1-(1H-INDOL-3-YL)-3-{5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YLOXY}PROPAN-2-AMINE,4-(4-CHLOROPHENYL)-4-4-(1H-PYRAZOL-4-YL)PHENYLPIPERIDINE,ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE,N-(1S)-2-amino-1-phenylethyl-5-(1H-pyrrolo2,3-bpyridin-4-yl)thiophene-2-carboxamide		0.00001	16714.3	G=569, A=1429		G=304/265, A=755/674	1	
chr20:36030939	C/C	G	SNV		SRC	exonic	1								100.00	p.(=)		934	G=0.0, C=1.0		Present				+	12	NM_198291.2	c.1218G>C	synonymous	-2.02				Protein kinase domain,Protein tyrosine kinase,SH2 domain,SH3 domain,Variant SH3 domain	rs1885257		0.012 (ref)					ATP binding,Ras protein signal transduction,SH2 domain binding,SH3/SH2 adaptor activity,T cell costimulation,axon guidance,blood coagulation,bone resorption,branching involved in mammary gland duct morphogenesis,caveola,cell adhesion,cell cycle,cell junction assembly,cellular membrane organization,cytoplasm,cytoskeleton,cytosol,ephrin receptor binding,epidermal growth factor receptor signaling pathway,fibroblast growth factor receptor signaling pathway,forebrain development,heme binding,integrin binding,interspecies interaction between organisms,intracellular protein kinase cascade,ion channel binding,kinase activity,leukocyte migration,mitochondrial inner membrane,mitochondrion,nerve growth factor receptor signaling pathway,non-membrane spanning protein tyrosine kinase activity,nucleotide binding,nucleus,oogenesis,peptidyl-tyrosine phosphorylation,phosphorylation,plasma membrane,platelet activation,positive regulation of integrin activation,protein binding,protein kinase activity,protein phosphorylation,protein tyrosine kinase activity,receptor binding,regulation of bone resorption,regulation of intracellular estrogen receptor signaling pathway,regulation of vascular permeability,response to interleukin-1,signal complex assembly,signal transduction,uterus development	(2E)-N-{4-(3-bromophenyl)aminoquinazolin-6-yl}-4-(dimethylamino)but-2-enamide,1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo3,4-dpyrimidin-4-amine,1-1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl-3-naphthalen-1-ylurea,1-1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl-3-phenylurea,1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo3,4-DPyrimidin-4-Ylamine,1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo3,4-dpyrimidin-4-amine,1-cyclopentyl-3-(1H-pyrrolo2,3-bpyridin-5-yl)-1H-pyrazolo3,4-dpyrimidin-4-amine,2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE,3-4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO3,4-DPYRIMIDIN-3-YLPHENOL,4-(4-METHYL-1-PIPERAZINYL)METHYL-N-3-4-(3-PYRIDINYL)-2-PYRIMIDINYLAMINOPHENYL-BENZAMIDE,4-({4-(5-cyclopropyl-1H-pyrazol-3-yl)aminoquinazolin-2-yl}amino)phenylacetonitrile,Citric Acid,DPI59,Dasatinib,ISO24,Malonic acid,N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE,N-4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL-ACRYLAMIDE,N6-Benzyl Adenosine-5'-Diphosphate,Oxalic Acid,PAS219,PASBN,Phenylphosphate,Phosphonotyrosine,Purvalanol A,RU78191,RU78262,RU78299,RU78300,RU78783,RU79072,RU79073,RU79256,RU81843,RU82129,RU82197,RU82209,RU83876,RU84687,RU85053,RU85493,RU90395		0.00001	14081.5	G=0, C=934		G=0/0, C=464/470	2	
chrX:66766604		G	GENE_EXPRESSION		AR								AR.E1E2				7038				Present			3.0963e-09																						0.0					
chrX:66905968		G	GENE_EXPRESSION		AR								AR-AR.A3A4.V7				102				Present			4.4873e-11																						0.0					
chrX:66931531		G	GENE_EXPRESSION		AR								AR-AR.A4A8.V12				81				Present			3.5635e-11																						0.0					
chrX:66941805		A	GENE_EXPRESSION		AR								AR-AR.A6A9.V18				28				Present			1.2318e-11																						0.0					
chrX:66942826		T	GENE_EXPRESSION		AR								AR-AR.E7E8.V14				158				Present			6.9510e-11																						0.0					
chrX:66942826		T	GENE_EXPRESSION		AR								AR.E7E8				145889				Present			6.4182e-08																						0.0					
